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Abstract	
CO2	is	a	product	of	aerobic	respiration	that	has	been	implicated	in	various	signalling	
pathways	in	health	and	disease.	However,	the	exact	mechanisms	of	CO2	signalling	are	
poorly	understood.	This	is	due	in	large	part	to	the	lack	of	technology	with	which	to	
study	 protein-CO2	 interactions,	 known	 as	 carbamylation,	 and	 thus	 identify	 CO2	
sensors.	 Recently	 a	 method	 for	 trapping	 carbamates,	 forming	 a	 carboxyethyl	
modification	to	the	target	residue,	has	been	developed	for	downstream	analysis	of	
carbamate	formation	by	MS.	The	aim	of	this	thesis	 is	to	use	this	novel	workflow	to	
identify	a	CO2	sensor.	MALDI-TOF	MS	was	performed	to	identify	peptides	containing	
carboxyethyl	modification.	LC-MS/MS	was	then	performed	to	identify	K33	and	K48	as	
sites	of	carboxyethyl	modification.	These	residues	were	demonstrated	to	be	sites	of	
carbamylation	 by	 introducing	 13C	 into	 the	 workflow.	 Finally,	 a	 cross-linking	 assay	
demonstrated	CO2-dependent	reduction	to	the	rate	of	ubiquitination.	Together	these	
results	 demonstrate	 two	 sites	 of	 carbamylation	 of	 ubiquitin	with	 consequences	 to	
ubiquitination	kinetics.	Therefore,	it	is	proposed	that	ubiquitin	is	a	CO2	sensor.	 	
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1. Introduction	
1.1. Overview	
Carbon	 dioxide	 (CO2)	 is	 a	 primary	 product	 of	 oxidative	 metabolism	 that	 was	 first	
discovered	by	Joseph	Black	in	the	18th	century	and	has	since	been	implicated	in	several	
human	diseases	(Cummins	et	al.,	2014;	West,	2014).	Fundamentally,	CO2	has	effects	
on	 respiration,	photosynthesis,	and	acid-base	homeostasis	 (Gutknecht	et	al.,	1977;	
Hetherington	and	Raven,	2005;	Joshi	and	Tabita,	1996).	It	readily	dissolves	into	cells	
due	to	its	hydrophobic	properties,	whereupon	it	becomes	hydrated	to	form	carbonic	
acid.	 Carbonic	 acid	 readily	 dissociates	 into	 HCO3
-	 and	 H+,	 thus	 linking	 the	
concentration	of	CO2	 in	a	cell	 to	the	pH	(Blombach	and	Takors,	2015;	Boron	et	al.,	
2011).	CO2	hydration	occurs	relatively	slowly	at	physiological	pH	and	is	therefore	the	
rate	 limiting	 step	 in	 the	 equilibrium	 (Khalifah,	 1973).	 In	 order	 to	 overcome	 this	
carbonic	anhydrase	catalyses	 the	hydration	of	CO2.	CAs	are	efficient	enzymes	with	
high	turnover	rates	(Frommer,	2010;	Lindskog,	1997).	Their	biological	importance	is	
demonstrated	by	their	evolutionary	conservation	in	all	kingdoms	of	life	(Moroney	et	
al.,	 2001;	 Supuran	 et	 al.,	 2003).	 This	 suggests	 the	 ability	 to	 sense	 and	 respond	 to	
changes	 in	CO2	 is	 an	 important	 homeostatic	mechanism.	However,	 this	 is	 a	 poorly	
understood	area	of	cell	biology	and	this	thesis	aims	to	better	understand	CO2	sensing.	
Therefore,	 the	 focus	 of	 this	 thesis	 is	 CO2	 signalling	 and	 its	 direct	 interaction	 with	
proteins.	
	
1.2. Carbamylation	
The	 direct	 interaction	 of	 CO2	 with	 proteins	 results	 in	 a	 labile	 post	 translational	
modification	(PTM),	which	is	referred	to	in	the	literature	with	a	range	of	definitions	
(e.g.	 carbamate,	 carbamino	 adduct,	 carboxylate).	 Herein,	 it	 is	 referred	 to	 as	 a	
carbamate.	 The	 reaction	 resulting	 in	 a	 carbamate,	 termed	 carbamylation,	 occurs	
between	 aqueous	 CO2	 and	 uncharged	 amine	 groups	 on	 proteins	 (Figure	 1.1).	
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Carbamylation	changes	the	electrochemical	properties	of	the	modified	protein.	This	
in	turn	alters	the	possible	interactions	and	therefore	function	of	the	modified	protein.	
	
	
Figure	1.1|	Mechanism	of	carbamate	formation.	
	
Carbamates	are	formed	by	the	nucleophilic	attack	of	a	neutral	amine	on	the	carbon	
atom	of	carbon	dioxide	(Ewing	et	al.,	1980;	Hampe	and	Rudkevich,	2003).	In	proteins,	
this	can	occur	at	the	N-terminal	residue	or	on	an	epsilon-amine	on	the	side	chain	of	
lysine	 residues.	 This	 results	 in	 a	 change	of	 charge	 status,	which	 influences	protein	
structure	 and/or	 interactions	 with	 other	 molecules	 (Lorimer	 and	 Miziorko,	 1980;	
Terrier	and	Douglas,	2010).	Carbamylation	is	a	labile	modification	that	occurs	within	
specific	environments	where	the	pKa	of	the	amine	group	 is	below	9.5	(Chen	et	al.,	
1993;	Jimenez-Morales	et	al.,	2014).	The	pKa	of	lysine	residues	is	typically	between	9	
and	13,	which	means	 that	 at	 physiological	 pH	 the	 amine	 is	 positively	 charged	 and	
consequently	 unable	 to	 form	 a	 carbamate	 (Abraham	 et	 al.,	 2009).	 However	
carbamates	readily	form	at	higher	pH	(Stadie	and	O'Brien,	1936).	Thus	it	 is	thought	
that	 specific	 structural	 folds	 that	 harbour	 a	 lower	 pKa	 are	 required	 for	 carbamate	
formation	(Cleland	et	al.,	1998)	
	
Le	Chatelier’s	principle	may	be	applied	to	carbamate	formation.	This	principle	states	
that	when	an	equilibrium	is	subject	to	change,	the	equilibrium	shifts	in	such	a	way	as	
to	counteract	the	change.	This	effectively	nullifies	the	applied	change.	When	applied	
to	 carbamate	 formation	 within	 a	 cellular	 context	 it	 is	 likely	 that	 the	 interaction	
between	CO2	and	a	neutral	amine	results	in	carbamate	formation	and	a	shift	in	the	
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equilibria	to	generate	more	neutral	amines	for	further	carbamate	formation	(Hackling	
and	Garnett,	1985).	Moreover,	the	sequestering	of	CO2	by	carbamate	formation	drives	
the	dissociation	of	CO2	 from	carbonic	 acid,	which	 is	 utilised	 for	 further	 carbamate	
formation.		
	
1.3. Examples	of	protein	carbamylation	
Carbamylation	occurs	on	proteins	found	in	all	kingdoms	of	life	(Table	1.1).	There	are	
a	wide	variety	of	physiological	processes	understood	to	be	entirely	dependent	upon	
CO2.	 Importantly,	 these	 proteins	 all	 demonstrate	 a	 physiologically	 relevant	
consequence	 of	 carbamylation	 i.e.	 the	 interaction	 of	 these	 proteins	 with	 CO2	
corresponds	 to	 a	 specific	 biological	 activity,	 rather	 than	 being	 an	 artefactual	
modification.	Despite	this,	the	list	of	proteins	reported	to	undergo	carbamylation	is	
relatively	 short.	 It	 is	 anticipated	 that	 there	 are	many	more	 proteins	 that	 undergo	
carbamylation	 in	 a	 physiologically	 relevant	 manner	 but	 these	 have	 not	 yet	 been	
reported.	This	is	due	to	a	technical	challenge	concerning	the	identification	of	a	labile	
modification.	Here	the	carbamylation	of	two	mammalian	proteins	is	discussed.	
Table	1.1|	List	of	known	protein	carbamates.	
Organism	 Protein	
Uniprot	
Accession	
Site	of	
Carbamylation	
Reference	
Homo	sapiens	 Haemoglobin	 P68871	 V1	 (Lorimer,	1983)	
Homo	sapiens	 Cx26	 P29033	 K125	
(Meigh	et	al.,	
2013)	
Spinacia	oleracea	 RuBisCO	 P00875	 K201	
(Lorimer	and	
Miziorko,	1980)	
Klebsiella	aerogenes	 Urease	 P18314	 K217	
(Yamaguchi	
and	Hausinger,	
1997)	
Pseudomonas	
diminuta	
Phosphotriesterase	 G8DNV8	 K169	
(Benning	et	al.,	
2001)	
Psuedomonas	
aeruginosa	
b	Lactamase	 P14489	 K70	
(Golemi	et	al.,	
2001;	
Maveyraud	et	
al.,	2000)	
Propionibacterium	
shermanii	
Transcarboxylase	 Q70AC7	 K184	
(Hall	et	al.,	
2004)	
Geobacillus	
stearothermophilus	
Alanine	Racemase	 P10724	 K129	
(Morollo	et	al.,	
1999)	
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1.3.1. Haemoglobin	
Haemoglobin	 is	well	 known	 for	 its	 role	 in	oxygen	 transportation	 in	 red	blood	cells.	
Oxygen	 dissociation,	 and	 therefore	 tissue	 oxygenation,	 is	 encouraged	 by	 a	
phenomenon	known	as	the	Bohr	effect.	This	is	where	an	increased	pCO2	in	the	blood	
decreases	 the	affinity	of	haemoglobin	 for	oxygen,	 facilitating	O2	dissociation	 (Hsia,	
1998).	The	deoxy-haemoglobin	is	then	able	to	bind	CO2	to	transport	it	from	respiring	
tissues	 to	 the	 lungs,	 from	where	 it	 is	expelled	 from	the	body.	The	 formation	of	N-
terminal	 carbamates	 on	 deoxy-haemoglobin	 is	 responsible	 for	 up	 to	 20%	 of	 CO2	
transport	from	tissues	to	the	lungs	(Lorimer,	1983;	Vandegriff	et	al.,	1991).	CO2	binds	
to	neutral	N-terminal	amino	groups	of	haemoglobin	to	form	carbamate	adducts	with	
a	preference	for	the	b	chains	rather	than	a	chains	(Kilmartin	et	al.,	1973;	Matthew	et	
al.,	1977).	
	
Dick	 et	 al.	 demonstrated	 that	 interference	 with	 N-terminal	 protonation	 perturbs	
carbamate	adduct	formation	(Dick	et	al.,	1999).	This	initially	seems	counterintuitive	
since	it	is	the	unprotonated	amine	group	that	is	able	to	interact	with	CO2	to	form	the	
adduct.	 Nonetheless	 Dick	 and	 colleagues	 show	 that	 perturbed	 carbamate	 adduct	
formation	 in	 these	 conditions	 is	 a	 true	 phenomenon	 because	 R141	 is	 also	
deprotonated,	 removing	 the	 cationic	 species	 that	 serves	 to	 stabilise	 the	 anionic	
carbamate	through	electrostatic	interactions	(Dick	et	al.,	1999).	This	is	an	important	
demonstration	 of	 carbamate	 stabilisation	 by	 the	 electrostatic	 interaction	 of	 a	
positively	charged	residue	in	close	proximity	to	the	labile	carbamate.	
	
1.3.2. Connexin	26	
Another	 example	 of	 carbamate	 stabilisation	 is	 observed	 in	 Connexin	 26	 (Cx26).	 A	
recent	paper	demonstrated	direct	detection	of	CO2	by	Cx26,	which	is	in	contrast	to	
the	then	commonly	held	belief	that	CO2	detection	occurred	by	proxy	of	pH	changes	
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(Huckstepp	et	al.,	2010a).	Cx26	 is	a	hemichannel	 that	 is	 sensitive	 to	CO2,	with	ATP	
release	evoked	upon	activation	of	this	gap	junction	in	order	to	mediate	downstream	
signalling	events	that	regulate	respiration	(Huckstepp	et	al.,	2010a).	Cx26	 is	one	of	
three	connexins	(Cx26,	Cx30,	and	Cx32)	that	are	sensitive	to	CO2	(Meigh	et	al.,	2013).	
During	this	investigation,	the	authors	observed	that	a	carbamylation	motif,	KVREI,	is	
present	 in	 each	 of	 these	 hemichannels	 whereby	 carbamate	 formation	 at	 K125	 is	
stabilised	by	formation	of	a	salt	bridge	with	R104.	This	carbamylation	motif	has	been	
introduced	to	a	CO2-insensitive	connexin,	Cx31.	The	introduction	of	this	motif	showed	
CO2-sensitive	function	in	a	manner	analogous	to	WT	Cx26.	K125R	or	R104A	mutation	
ablated	the	sensitivity	of	Cx26	to	CO2.	Moreover,	introduction	of	K125E	to	Cx26,	which	
is	analogous	to	carbamylated	K125,	resulted	in	a	constitutively	open	hemichannel.	It	
is	clear	from	these	genetic	manipulations	that	carbamylation	of	K125	is	required	for	
appropriate	activation	of	Cx26	in	a	CO2-sensitive	fashion.	This	has	broad	implications	
for	vertebrate	physiology,	whereby	it	has	been	demonstrated	that	the	affinity	of	Cx26	
has	 evolved	 in	 a	 species-specific	 manner	 to	 suit	 the	 P	 CO2	 of	 the	 environment,	
highlighting	the	importance	of	respiratory	regulation	(de	Wolf	et	al.,	2017).		
	
1.4. CO2	in	signalling	pathways	
Recent	 studies	 indicate	 that	 CO2	 acts	 effectively	 as	 a	 small	 signalling	molecule.	 In	
particular,	CO2	alters	the	activity	of	many	membrane	transporters.	This	regulation	can	
occur	 by	 direct	 interaction	 of	 CO2	 with	 the	 membrane	 protein	 or	 indirectly	 by	
signalling	 events	 typically	 downstream	 of	 CO2-dependent	 changes	 to	 intracellular	
cAMP	concentrations.		
	
1.4.1. Direct	CO2	signalling	
CO2	binds	 to	Cx26,	a	hemichannel,	at	K125	 to	 form	a	carbamate	bridge	with	R104	
(Meigh	 et	 al.,	 2013).	 This	 interaction	 causes	 Cx26	 to	 open,	 resulting	 in	 ATP	 efflux	
(Huckstepp	et	al.,	2010b).	This	release	of	ATP	has	downstream	effects	that	contribute	
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to	 the	 chemosensitive	 regulation	 of	 respiratory	 drive	 (Huckstepp	 et	 al.,	 2010a).	 In	
addition	to	Cx26	a	K+	influx	channel,	Kir,	has	also	been	reported	to	be	responsive	to	
direct	binding	of	CO2.	However,	a	direct	interaction	between	CO2	and	Kir	has	not	yet	
been	demonstrated	(Huckstepp	and	Dale,	2011).	
	
1.4.2. Indirect	CO2	signalling	
Indirect	 regulation	 of	 membrane	 transporters	 by	 CO2	 is	 due	 to	 CO2-dependent	
changes	in	cAMP	levels	(Turner	et	al.,	2016).	Na+/HCO3
-	cotransporter	(NBC)	activity	is	
upregulated	in	the	context	of	elevated	CO2	levels	(Adijanto	et	al.,	2009),	whilst	Cl
-	and	
fluid	secretions	by	CFTR	are	reduced	in	similar	conditions	(Turner	et	al.,	2016).	This	is	
in	agreement	with	other	research	that	observes	CO2-dependent	decreases	in	cAMP	
production	and	corresponding	cAMP-dependent	signalling	in	kidney	cells	(Cook	et	al.,	
2012).	 However,	 there	 are	 also	 reported	 instances	 of	 CO2-dependent	 increases	 in	
cAMP	production	and	signalling	(Lecuona	et	al.,	2013;	Townsend	et	al.,	2009).	Na+/K+	
ATPase	proteins	are	also	negatively	regulated	in	hypercapnic	conditions	(Briva	et	al.,	
2007).	 The	 role	 of	 CO2	 in	 the	 negative	 regulation	 of	 Na
+/K+	 ATPase	 activity	 is	 to	
upregulate	Na+/K+	ATPase	endocytosis	 (Vadasz	et	al.,	2008).	Thus,	hypercapnia	has	
differential	 effects	 of	 membrane	 transporter	 activity	 that	 is	 cell	 type	 and	 tissue	
context	dependent.	A	challenge	going	forwards	is	to	define	the	exact	mechanism	of	
action	of	CO2	in	these	signalling	pathways.	The	binding	site	of	CO2	is	known	for	Cx26	
and	this	has	been	informative	to	deepen	the	understanding	of	the	regulation	of	this	
protein.	Such	clarity	is	desired	for	the	other	signalling	processes	described.		
	
1.4.3. NFkB	Signalling	
The	 NFκB	 family	 of	 transcription	 factors	 belong	 to	 one	 of	 two	 distinct	 signalling	
pathways,	canonical	and	non-canonical.	Release	of	the	active	transcription	factor	 is	
essential	in	both	pathways,	and	the	mechanism	by	which	it	is	released	categorises	the	
type	of	NFκB	pathway.		
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Canonical	 NFκB	 signalling	 requires	 the	 proteasomal	 degradation	 of	 IκB	 to	 release	
NFκB,	 whilst	 non-canonical	 NFκB	 signalling	 requires	 the	 proteolytic	 processing	 of	
precursors.	Typically,	p100	and	p105	are	cleaved	to	p52	and	p50,	respectively,	which	
form	a	heterodimer	to	achieve	transcriptional	regulation.	
	
1.4.3.1. Canonical	NFκB	signalling	
The	key	irreversible	step	in	canonical	NFkB	signalling	is	the	release	of	the	cytoplasmic	
inhibitor,	 IkB,	 via	 proteolysis.	 IkB	 degradation	 releases	 NFkB,	 allowing	 for	 nuclear	
translocation	and	subsequent	association	with	DNA	to	initiate	transcription	of	target	
genes.	 One	 of	 these	 target	 genes	 is	 IκB,	 which	 associates	 with	 NFkB	 to	 perform	
nuclear	export	of	the	transcription	factor	(Brown	et	al.,	1993;	Karin	and	Ben-Neriah,	
2000).	Therefore,	the	activation	and	termination	of	NFkB	mediated	gene	expression	
is	tightly	regulated	by	IkB	(Beg	et	al.,	1993;	Sun	et	al.,	1993).		
	
Initial	experiments	demonstrating	dissociation	of	IkB	as	an	important	activation	step	
in	NFkB	signalling	were	performed	using	detergent	(Baeuerle	and	Baltimore,	1988).	
Furthermore,	 it	 was	 revealed	 that	 phosphorylation	 of	 IkB	 was	 essential	 for	 its	
degradation	 and	 that	 inhibiting	 IkB	 degradation	 prevented	 NFkB	 activation.	 This	
group	 also	 demonstrated	 that	 phosphorylation	 alone	 was	 not	 sufficient	 for	 NFkB	
activation,	suggesting	an	additional	regulatory	factor	is	involved	(Henkel	et	al.,	1993).	
This	 additional	 layer	 of	 regulation	 was	 demonstrated	 to	 be	 ubiquitination	 and	
subsequent	 proteasomal	 degradation	 of	 phosphorylated	 IkB	 (Alkalay	 et	 al.,	 1995;	
Chen	et	al.,	1995).	
	
In	the	canonical	NFkB	pathway	elevated	CO2	has	been	shown	to	induce	reversible	IKK	
nuclear	translocation	(Cummins	et	al.,	2010).	IKK	phosphorylates	IκB,	thus	priming	it	
for	 ubiquitination	 and	 proteasomal	 degradation.	 The	 nuclear	 translocation	 of	 IKK	
prevents	phosphorylation	of	IkB.	This	in	turn	prevents	degradation	of	IkB	so	that	NFkB	
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remains	sequestered	in	the	cytoplasm.		It	is	unclear	where	exactly	CO2	modulates	the	
activity	of	the	signalling	cascade,	since	there	are	multiple	upstream	steps	that	could	
be	 influenced.	 This	 suppression	 of	 NFkB	 signalling	 results	 in	 innate	 immune	
suppression,	 which	 is	 also	 observed	 in	 rats	 that	 are	 still	 able	 to	 perform	 renal	
buffering,	suggesting	the	effect	is	CO2	mediated	and	independent	of	pH	(Nichol	et	al.,	
2009).	It	is	thought	that	CO2-mediated	immune	suppression	may	be	beneficial	to	the	
overall	health	of	an	individual	as	a	method	of	tolerating	metabolic	stress	(Amato	et	
al.,	1998;	Hanly	et	al.,	2006;	Laffey	et	al.,	2004).	
	
1.4.3.2. Non-canonical	NFκB	signalling	
In	 the	 non-canonical	 NFkB	 signalling	 pathway	 ubiquitination	 and	 proteasomal	
degradation	 enables	 the	 generation	 of	 the	 active	 NFkB	 subunit,	 p50,	 from	 its	
precursor,	p105	(Palombella	et	al.,	1994).	Sequence	homology	identified	a	conserved	
N-terminal	sequence	containing	two	serine	residues,	at	positions	32	and	36,	that	are	
essential	for	phosphorylation	and	subsequent	ubiquitin-mediated	IkB	degradation	by	
the	 proteasome	 (Brown	 et	 al.,	 1995;	 Chen	 et	 al.,	 1995;	 Yaron	 et	 al.,	 1997).	 The	
importance	of	this	conserved	sequence	was	highlighted	by	comparing	the	half-life	of	
IkB	in	resting	cells	and	activated	cells.	In	the	former	the	half-life	is	approximately	140	
minutes,	whilst	in	activated	cells	it	is	approximately	1.5	minutes	(Henkel	et	al.,	1993).	
	
An	SCF	E3	ligase	is	responsible	for	the	ubiquitination	of	phosphorylated	IkB,	p100	and	
p105	 for	 their	 subsequent	 interaction	with	 the	 proteasome	 (Fong	 and	 Sun,	 2002;	
Heissmeyer	et	al.,	2001;	Orian	et	al.,	2000;	Wu	and	Ghosh,	1999).	It	achieves	this	by	
bringing	the	substrate	lysine	of	IkB	into	closer	proximity	to	the	E2~ubiquitin	complex,	
permitting	 more	 efficient	 ubiquitin	 transfer	 (Wu	 et	 al.,	 2003).	 The	 SCF	 E3	 ligase	
recognises	phosphorylated	proteins	through	its	beta-TrCP	subunit	(Yaron	et	al.,	1998).	
Its	ability	to	differentiate	between	various	substrate	phosphoproteins	 is	due	to	the	
protein	 recognition	 subunit,	 F	 box	 protein	 (FBP),	 which	 has	 a	 protein	 recognition	
domain	at	its	C-terminus	(Cardozo	and	Pagano,	2004;	Deshaies,	1999).	
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Members	of	 the	non-canonical	NFkB	signalling	pathway	have	been	 reported	 to	be	
sensitive	to	CO2	(Oliver	et	al.,	2012).	This	effect	has	also	been	observed	in	downstream	
genes	 of	 Relish,	 an	NFkB	orthologue	 in	D.	melanogaster	 (Helenius	 et	 al.,	 2009).	 A	
recent	 paper	 recorded	 the	 first	 identification	 of	 a	 conserved	 20	 amino	 acid	 CO2	
responsive	domain	(CORD)	located	at	the	C-terminus	of	RelB	(Keogh	et	al.,	2017).	RelB	
is	subject	to	multiple	PTMs	(Hailfinger	et	al.,	2009;	Marienfeld	et	al.,	2001;	Neumann	
et	al.,	2011).	After	being	subject	to	hypercapnic	conditions	RelB	is	cleaved	at	the	CORD	
(Keogh	et	al.,	2017).	The	CORD	is	situated	within	the	transactivation	domain	of	RelB,	
which	explains	the	reduced	NFkB	mediated	gene	expression	observed	in	hypercapnic	
conditions	(Perkins,	2007).	It	was	also	shown	that	p100	nuclear	translocation	occurs,	
and	this	is	thought	to	be	important	for	the	NFkB-dependent	response	to	CO2	(Keogh	
et	 al.,	 2017).	 One	 explanation	 for	 this	 may	 be	 due	 to	 the	 prerequisite	 of	 p100	
processing	 to	 p52	 for	 normal	 non-canonical	 NFkB	 signalling	 activation.	 The	 intact	
p100	 subunit	 may	 prevent	 DNA	 binding	 through	 the	 Rel	 homology	 domain	 and	
consequently	 attenuate	 non-canonical	 NFkB	 signalling.	 In	 addition	 to	 this	 the	
polyubiquitination	of	RelB	augments	transcriptional	activity.	This	occurs	despite	K48R	
K63R	double	mutants	of	ubiquitin	(Leidner	et	al.,	2008).	This	suggests	that	ubiquitin	is	
linked	through	isopeptide	bonds	formed	at	alternative	lysine	residues	to	K48	and	K63.		
	
It	was	 recently	 identified	 that	 heat	 shock	 factor	 1	 (HSF1),	 a	 heat	 shock	 protein,	 is	
upregulated	 in	 hypercapnia.	 This	 is	 associated	 with	 decreased	 expression	 of	
proinflammatory	cytokines	(Lu	et	al.,	2018).	HSF1	has	previously	been	implicated	as	a	
NFκB	inhibitor,	which	suggests	the	mechanism	for	hypercapnic	immune	suppression	
is	through	increased	expression	of	HSF1	(Lu	et	al.,	2018;	Song	et	al.,	2008).		
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1.4.3.3. D.	melanogaster	development	
Embryonic	 development	 and	 egg	 laying	 are	 developmental	 processes	 that	 are	
perturbed	 by	 hypercapnic	 conditions.	 This	 is	 independent	 of	 the	 CO2	 sensitive	
neurones,	Gr63a	(Helenius	et	al.,	2009).	RNAi	knockdown	of	Zfh2	partially	restored	
the	effects	of	elevated	CO2	on	egg	hatching	(Helenius	et	al.,	2016a).		
	
1.5. CO2	in	pathology	
1.5.1. Perturbed	fluid	reabsorption	in	pulmonary	disease	
Patients	 with	 acute	 respiratory	 distress	 syndrome	 (ARDS)	 or	 COPD	 present	 with	
hypercapnia.	Fluid	 reabsorption	at	 the	alveolar	epithelium	 is	critical	 to	maintaining	
optimal	gas	exchange	in	the	lungs.	This	is	achieved	by	the	active	transport	of	fluid	into	
the	 cell	 by	 the	Na+/K+	ATPase	 (Matthay	et	 al.,	 2002;	 Sznajder,	 2001;	Vadasz	et	 al.,	
2007).	 Hypercapnia	 decreases	 Na+/K+	 ATPase	 activity,	 which	 impairs	 alveolar	 fluid	
reabsorption	and	leads	to	alveolar	epithelial	dysfunction	(Briva	et	al.,	2007;	Vadasz	et	
al.,	2008).	This	is	also	observed	in	Drosophila	(Helenius	et	al.,	2009).	Decreased	Na+/K+	
ATPase	is	achieved	through	JNK-dependent	endocytosis	of	the	Na+/K+	ATPase.	Here,	
AMPK	 and	 PKC-zeta	 are	 activated	 which	 causes	 activation	 of	 JNK	 through	 its	
phosphorylation	 at	 S129	 (Vadasz	 et	 al.,	 2012).	 Endocytosis	 of	 this	 pump,	 and	 the	
resulting	alveolar	epithelial	dysfunction,	worsens	prognosis	in	patients	with	COPD	and	
ARDS.		
	
1.5.2. Muscle	atrophy	in	pulmonary	disease	
Muscle	atrophy	 is	 recognised	as	a	major	 contributor	 to	worse	clinical	outcomes	 in	
patients	with	pulmonary	disease	(Celli	et	al.,	2004)	and	recovery	of	muscle	mass	 in	
COPD	patients	has	proven	to	be	beneficial	to	pulmonary	rehabilitation	(Puhan	et	al.,	
2011).	Recent	research	has	demonstrated	that	hypercapnia	stimulates	skeletal	muscle	
degradation	 via	 the	 ubiquitin	 proteasomal	 degradation	 pathway	 (Jaitovich	 et	 al.,	
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2015).	Here,	AMPKa2	is	readily	phosphorylated	in	the	presence	of	elevated	CO2	levels.	
This	causes	an	increase	in	FoxO3a	activation	which	in	turn	upregulates	expression	of	
muscle-specific	ubiquitin-E3	ligases	muscle	RING	finger	1	(MuRF1).	The	upregulation	
of	 MuRF1	 in	 muscle	 atrophy	 is	 consistent	 with	 other	 reports	 despite	 different	
upstream	signalling	events	occurring	(Glass,	2005).	The	results	obtained	by	Jaitovich	
and	 colleagues	 showed	 that	 the	 hypercapnia-induced	 muscle	 atrophy	 was	
independent	of	pH	change	and	therefore	this	effect	must	be	due	to	carbamylation.	
The	substrate	for	carbamylation	has	not	been	identified.	
	
1.5.3. Hypercapnia	mediates	immune	suppression	
Hypercapnia	 induces	expression	of	metabolic	and	decreases	expression	of	 immune	
genes	in	Drosophila	(Helenius	et	al.,	2009).	This	was	shown	to	be	independent	of	a	
neuronal	CO2	sensing	pathway,	suggesting	a	role	for	a	cell	autonomous	CO2	sensing	
pathway.	The	identified	genes	repressed	in	hypercapnia	are	under	regulatory	control	
of	 the	 NFκB	 transcription	 factor.	 Similarly,	 studies	 in	 mammalian	 alveolar	
macrophages	have	implicated	NFκB	in	a	CO2–responsive	signalling	pathway	whereby	
increased	levels	of	CO2	suppress	expression	of	proinflammatory	cytokines	(Wang	et	
al.,	 2010).	 Importantly,	 both	 of	 these	 aforementioned	 studies	 demonstrated	 the	
effect	of	hypercapnia	on	 immune	suppression	 (1)	was	 independent	of	acidosis,	 (2)	
increased	mortality	from	specific	bacterial	infection,	and	(3)	occurred	independently	
of	 IκB	 proteolysis	 in	 the	 NFκB	 pathway.	 These	 results	 suggest	 an	 evolutionary	
conserved	 mechanism	 of	 CO2	 signalling	 that	 regulates	 immune	 and	 inflammatory	
pathways	with	physiological	consequences.	
	
A	 recent	 RNAi	 screen	 identified	 Zfh2	 as	 a	 mediator	 of	 hypercapnic	 immune	
suppression	in	D.	melanogaster	(Helenius	et	al.,	2016a).	Zfh2	is	expressed	in	adipose	
tissue,	which	is	the	major	immune	organ	of	Drosophila.	Knockdown	of	Zfh2	in	ex-vivo	
cultured	fat	bodies	expressed	2-fold	more	diptericin	compared	to	control	in	buffered	
hypercapnic	conditions.	This	corresponds	to	improved	survival	of	S.	aureus	infection.	
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Zfh2	has	mammalian	homologs,	ZFHX3	and	ZFHX4.	It	is	not	yet	understood	whether	
these	 transcription	 factors	 also	 mediate	 hypercapnic	 immune	 suppression	 in	
mammals	 but	 if	 this	 were	 confirmed	 it	 would	 suggest	 an	 evolutionary	 conserved	
pathway	 through	 which	 CO2	 mediates	 immune	 suppression.	 The	 authors	 of	 this	
investigation	are	quick	to	point	out	that	there	is	more	to	be	understood	about	this	
process.	In	particular,	it	is	likely	that	Zfh2	is	the	effector	and	that	the	CO2	sensor	is	yet	
to	be	identified	(Helenius	et	al.,	2016a).		
	
Several	 compounds	 have	 recently	 been	 identified	 that	 improve	 the	 expression	 of	
antimicrobial	peptides	during	hypercapnia	(Helenius	et	al.,	2016b).	Of	these,	evoxine,	
a	furoquinolone	alkaloid,	increased	the	expression	of	the	pro-inflammatory	cytokines	
IL-6	and	CCL2	in	mammalian	alveolar	macrophages	during	hypercapnia.	This	is	the	first	
demonstration	of	using	a	small	pharmacological	compound	to	reverse	the	effects	of	
hypercapnia,	which	provides	 the	platform	upon	which	 further	 research	can	aim	 to	
therapeutically	 target	 hypercapnic	 pathologies.	 Of	 particular	 importance	 will	 be	
structural	 studies	 that	 elucidate	 the	 precise	 interaction	 between	 these	 small	
molecules	 and	 their	 targets.	 This	 will	 inform	 future	 studies	 aiming	 to	 generate	
pharmacological	agents	with	which	to	treat	pathologies	actively	enhanced	by	elevated	
CO2	levels.	
	
1.6. Thesis	outline	
The	 biological	 question	 underpinning	 this	work	 is	 how	 cells	 sense	 and	 respond	 to	
changes	in	CO2	levels.	CO2	is	a	product	of	aerobic	respiration	and	could	therefore	act	
as	a	signalling	molecule	to	contribute	to	the	metabolic	status	of	the	cell.	A	greater	
understanding	 of	 this	 biological	 phenomenon	 will	 broaden	 understanding	 of	
fundamental	 biological	 processes	 linking	 cellular	 metabolism	 and	 homeostasis.	
Elevated	 CO2	 levels	 are	 observed	 in	 patients	 with	 pulmonary	 disease	 and	 this	
hypercapnia	has	been	reported	to	worsen	prognosis.	Therefore,	 this	work	will	also	
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contribute	to	a	greater	understanding	of	the	pathophysiology	of	these	diseases	which,	
in	turn,	will	lead	to	the	development	of	therapies	to	treat	these	diseases.		
	
CO2	 has	 previously	 been	 demonstrated	 a)	 to	 bind	 directly	 to	 proteins	 to	 form	
carbamates	b)	to	be	 involved	 in	cellular	signalling	processes	c)	to	both	directly	and	
indirectly	regulate	protein	activity	and	d)	to	contribute	to	pathological	states.	A	recent	
proteomics	using	A.	thaliana	leaf	lysate	investigation	suggests	ubiquitin	is	susceptible	
to	carbamylation	(Linthwaite,	2016).	In	this	screen	ubiquitin	was	identified	as	a	high	
confidence	 candidate,	with	 a	 similarly	 low	probability	of	 error	 score	as	RuBisCO,	 a	
bona	fide	target	of	CO2-dependent	carbamylation.	Despite	this,	carbamate	formation	
on	ubiquitin	was	not	validated.	
	
Ubiquitin	 is	 a	 small	 (~8	 kDa)	 evolutionary	 conserved	 protein	with	 broad	 signalling	
functions	(Chen,	2005;	Finley	and	Chau,	1991).	Ubiquitin	is	conjugated	to	substrate	
proteins	 through	 a	 series	 of	 reactions	 catalysed	by	 enzymes	 from	 the	3	 classes	 of	
ubiquitin	ligases.	The	activating	E1	ligase	forms	a	thiol	ester	with	the	carboxyl	group	
of	ubiquitin	G76.	The	conjugating	E2	ligase	forms	a	thiolester	with	G76.	The	E3	ligase	
transfers	ubiquitin	from	the	E2	 ligase	to	the	substrate,	forming	an	 isopeptide	bond	
between	the	substrate	lysine	Ne-amine	group	and	G76	of	ubiquitin	(Pickart,	2001).	A	
polyubiquitin	 chain	 forms	 when	 further	 ubiquitin	 molecules	 are	 conjugated.	 The	
diverse	 array	 of	 ubiquitin	 signalling	 is	 conferred	 through	 the	 type	 and	 mode	 of	
ubiquitin	cross-linking.	PTMs	occurring	on	ubiquitin	itself	regulate	its	ability	to	cross-
link	(Matsuda,	2016).	CO2-dependent	carbamylation	and	ubiquitin	cross-linking	both	
occur	 on	 lysine	 residues,	 suggesting	 a	 physiologically	 relevant	 role	 for	 ubiquitin	
carbamylation.		
	
Altogether,	 the	hypothesis	of	 this	work	 is	 that	CO2	binds	directly	 to	ubiquitin	with	
physiologically	 relevant	 consequences.	 To	 investigate	 this	 hypothesis	 a	 mass	
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spectrometry	approach	is	taken	to	investigate	CO2-dependent	carbamate	formation	
on	ubiquitin.	Upon	confirmation	of	two	sites	of	carbamylation,	a	functional	assay	is	
performed	to	investigate	the	consequence	of	carbamate	formation.	 	
	
29	
2. Methods	
2.1. E.	coli	strains	
Table	2|	E.	coli	strains	and	genotypes	used	for	expression	of	recombinant	proteins.	
Strain	 Genotype	
BL21	(DE3)	 F–	ompT	hsdSB	(rB
–	mB
–)	gal	dcm	(DE3)	
Rosetta	(DE3)	pLysS	 F-	ompT	hsdSB(rB
-	mB
-)	gal	dcm	(DE3)	pLysSRARE	(CamR)	
Rosetta	2	(DE3)	pLysS	 F-	ompT	hsdSB(rB
-	mB
-)	gal	dcm	(DE3)	pLysSRARE2	(CamR)	
	
2.2. Protein	expression	and	purification	
2.2.1. pET	28	mE1	
BL21	(DE3)	were	transformed	with	pET28	mE1	 (a	gift	 from	Jorge	Eduardo	Azevedo	
(Addgene	plasmid	#32534))	and	protein	expression	was	 induced	by	addition	of	0.5	
mM	 IPTG	 at	 an	OD600	 0.6	 for	 20	 hours	 at	 16
oC	 (Carvalho	 et	 al.,	 2012).	 Cells	were	
harvested	at	4000	g	and	subjected	to	a	freeze-thaw	cycle	before	being	resuspended	
in	E1	Lysis	buffer	(50	mM	Tris-HCl	pH	8.0,	150	mM	NaCl	0.1%	(w/v),	Triton	X-100,	1	
mM	EDTA-NaOH	pH	8.0,	1	mM	DTT,	0.1	mg/mL	phenylmethylsulfonyl	fluoride,	1:500	
(v/v)	 Sigma	 mammalian	 protease	 inhibitor	 mixture)	 and	 lysed	 by	 sonication.	 The	
soluble	fraction	was	obtained	after	centrifugation	at	21,000	g	and	incubated	with	0.5	
mL	Ni2+	NTA	resin	per	1	L	pellet	for	2	hours	at	4oC	with	end	to	end	agitation.	The	resin	
was	washed	with	15	BV	wash	buffer	(50	mM	sodium	phosphate	pH	8.0,	150	mM	NaCl)	
and	eluted	with	3	x	1	BV	elution	buffer	(wash	buffer,	100	mM	imidazole).	The	eluted	
fractions	 were	 resolved	 on	 SDS-PAGE	 and	 fractions	 containing	 mE1	 were	 pooled,	
concentrated	and	buffer	exchanged	into	AEC	buffer	(10	mM	Tris-HCl	pH	8.0,	0.1	mM	
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EDTA-NaOH	pH	8.0,	1	mM	DTT).	This	was	loaded	onto	Bio-Scale	Mini	Macro-Prep	High	
Q	Cartridge	(Bio-Rad)	at	a	flow	rate	of	0.5	ml/min.	and	eluted	with	a	linear	gradient	
of	0	 -	0.5	M	NaCl	 in	AEC	elution	buffer	 (AEC	buffer,	0.5	M	NaCl).	 Following	buffer	
exchange	to	SEC	Buffer	(20	mM	Tris	HCl	pH	8.0,	100	mM	NaCl,	1	mM	EDTA-NaOH	pH	
8.0,	1	mM	DTT)	mE1	was	loaded	onto	Superose	12	column	HR	10/30	(GE	Healthcare)	
with	 flow	rate	of	0.5	mL/min	and	fractions	were	resolved	by	SDS-PAGE.	Fractions	
containing	mE1	were	pooled,	concentrated,	and	stored	at	-80oC.	
	
2.2.2. pGEX-4T	E2-25K	
Rosetta	 (DE3)	pLysS	 cells	were	 transformed	with	pGEX-4T	E2-25K	 (a	gift	 from	Titia	
Sixma	 (Addgene	plasmid	#63572))	and	grown	 to	an	OD600	0.7	at	37
oC.	GST-E2-25K	
expression	was	induced	with	0.5	mM	IPTG	for	20	hours	at	16oC	(Pichler	et	al.,	2005).	
Cells	were	harvested	at	4000	g	and	 subjected	 to	a	 freeze-thaw	cycle	before	being	
resuspended	in	E2	Lysis	buffer	(50	mM	Tris-HCl	pH	7.6,	1	mM	EDTA,	2	mM	DTT,	1	mM	
PMSF)	 and	 lysed	 by	 sonication.	 The	 soluble	 fraction	 was	 obtained	 following	
centrifugation	at	21,000	g	and	passed	over	0.8	mL	SuperGlu	resin	per	1	L	pellet	at	a	
flow	rate	of	0.5	mL/min.	The	resin	was	then	washed	with	10	BV	1x	PBS	before	GST-E2-
25K	 (herein	 referred	 to	 as	 E2-25K)	was	 eluted	with	 1	 BV	 1x	 PBS,	 10	mM	 reduced	
glutathione	and	dialysed	for	16	hours	into	GF	buffer	(20	mM	Tris-HCl	pH	8.0,	300	mM	
NaCl,	1	mM	DTT,	1	mM	EDTA).	E2-25K	was	then	loaded	onto	a	Superdex	75	column	at	
a	flow	rate	of	1	mL/min.	Fractions	were	resolved	by	SDS-PAGE	and	those	containing	
E2-25K	were	pooled,	concentrated,	and	stored	at	-80oC.			
	
2.2.3. Ubiquitin	(Homo	sapiens)	
BL21	 (DE3)	cells	containing	pET28	UBC	 (a	gift	 from	Rachel	Klevit	 (Addgene	plasmid	
#12647))	were	grown	to	an	OD600	0.6.	Ubiquitin	expression	was	induced	with	0.5	mM	
IPTG	for	16	hours	at	16oC	(Brzovic	et	al.,	2006).	Cells	were	harvested	at	4000	g	and	
lysed	by	sonication	in	50	mM	Tris-HCl	pH	8.0,	150	mM	NaCl,	0.1%	(w/v)	Triton	X-100,	
1	mM	EDTA-NaOH	pH	8.0,	1	mM	DTT,	Protease	inhibitor	cocktail	(Thermo	Scientific).	
Soluble	 protein	 was	 separated	 from	 cell	 debris	 by	 centrifugation	 at	 21,000	 g	 and	
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incubated	with	1	mL	Ni2+-NTA	resin	(50%	slurry)	for	2	hours	with	end	to	end	shaking.	
Weakly	bound	protein	was	washed	with	10	BV	50	mM	Tris-HCl	pH	8.0,	150	mM	NaCl,	
10	mM	 Imidazole.	 Bound	protein	was	eluted	across	 a	 range	of	 50	mM	–	250	mM	
imidazole.	 Each	 protein	 fraction	 was	 stored	 at	 -80oC	 in	 elution	 buffer	 with	 20%	
glycerol.	
	
2.2.4. Ubiquitin	(Arabadopsis	thaliana)	
Rosetta	2	(DE3)	pLysS		cells	containing	pET30a	UBQ11	(a	gift	from	Ari	Sadanandom)	
were	grown	to	an	OD600	0.7,	at	which	point	Ubiquitin	expression	was	induced	with	1	
mM	IPTG	for	4	hours	at	37oC	(Pangestuti,	2009).	Cells	were	harvested	at	4000	g	and	
lysed	in	50	mM	Tris-HCl	pH	8.0,	150	mM	NaCl,	1	mM	EDTA-NaOH	pH	8.0,	protease	
inhibitor	 cocktail	 (Sigma).	 Soluble	 protein	 was	 separated	 from	 cell	 debris	 by	
centrifugation	at	21,000	g	before	incubation	with	2	mL	Ni2+-NTA	resin	(50%	slurry)	for	
1.5	hours	with	end	to	end	shaking.	Weakly	bound	protein	was	washed	with	10	BV	50	
mM	Tris-HCl	pH	8.0,	150	mM	NaCl,	10	mM	Imidazole.	Bound	protein	was	eluted	across	
a	range	of	50	mM	–	250	mM	imidazole.	Each	protein	fraction	was	stored	at	-80oC	in	
elution	buffer	with	20%	glycerol.	
	
2.3. CO2	trapping	experiment	
0.5	mg	purified	recombinant	protein	was	dialysed	into	50	mM	Phosphate	Buffer	pH	
7.4.	The	trapping	reaction	mixture	was	supplemented	with	20	mM	NaHCO3	and	the	
trapping	 reaction	 was	 initiated	 by	 addition	 of	 10x	molar	 excess	 of	 TEO.	 The	 total	
volume	for	the	trapping	reaction	was	4	mL	at	t=0	and	titration	of	1	M	NaOH	ensured	
that	 the	 pH	was	maintained	 at	 7.4	 for	 1	 hour	 before	 terminating	 the	 reaction	 by	
dialysing	into	dH2O.	
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2.4. Physical	Chemistry	
2.4.1. FASP	Trypsin	Digest	
Following	dialysis	the	insoluble	protein	was	obtained	by	centrifugation	at	5000	g	for	
10	minutes.	The	protein	aggregate	was	resuspended	in	1%	SDS	and	trypsinolysis	was	
performed	using	the	FASP	trypsin	digest	kit	according	to	the	manufacturer’s	protocol	
(Wisniewski	et	al.,	2009).	
	
2.4.2. Sample	concentration	using	ZipTip	
TFA	 was	 added	 to	 samples	 at	 a	 final	 concentration	 0.01	 %	 (v/v).	 Washing	 was	
performed	with	100	%	acetonitrile	and	then	equilibrated	with	0.1	%	TFA.	30	µL	sample	
was	immobilised	and	washed	with	0.1	%	(v/v)	TFA.		Finally,	peptides	were	eluted	in	
0.1	%	TFA	50	%	acetonitrile	(v/v).		
	
2.4.3. Sample	fractionation	using	StageTip	
Sample	 fractionation	 was	 performed	 using	 a	 C18	 StageTip	 according	 to	
manufacturer’s	protocol	(Rappsilber	et	al.,	2007).	Peptides	were	fractionated	using	a	
50	–	500	mM	ammonium	acetate	gradient.	
	
2.4.4. MALDI-TOF	MS	
0.3	µg	peptide	samples	were	mixed	with	a-CHCA,	50	%	CAN,	0.05	%	TFA	at	a	ratio	1:1	
and	applied	to	the	MALDI	plate.	Following	20	min	incubation	at	room	temperature	the	
plate	was	placed	 in	the	 ion	source.	Data	collection	was	performed	using	4800	plus	
TOF/TOF	Analyzer	(SCIEX)	utilising	100	pulse	shots	with	variable	laser	intensity.	
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2.4.5. LC-MS/MS	
0.3	µg	samples	were	resuspended	in	2	%	ACN,	0.1	%	formic	acid	and	injected	at	a	flow	
rate	0.1	mL/min	over	a	2	hour	gradient	from	2	–	80	%	ACN,	0.1	%	formic	acid.	Peptides	
eluted	from	the	acetonitrile	gradient	were	resolved	using	TripleTOF	6600	Quadrupole	
time	of	flight	(QTOF;	SCIEX)	in	data	dependent	acquisition	(DDA)	mode	implementing	
top	 30	 precursor	 ion	 selection	 over	 10	 ms	 acquisition	 time.	 Selected	 peptide	
fragmentation	was	achieved	by	CID.	
	
2.4.6. Data	Analysis	
The	LC-MS/MS	data	was	analysed	using	the	GPM	database	X!Tandem	and	MaxQuant.	
Carbamidomethyl	cysteine	was	searched	for	as	a	fixed	variable,	whilst	carboxyethyl	
(72.0211	 Da)	 and	 ethyl	 (28.0313	 Da)	 transfer	 were	 searched	 for	 as	 variable	
modifications.	Parent	ion	mass	error	was	set	to	+/-	20	ppm	and	reverse	peptides	were	
enabled.	The	searches	were	performed	against	Human	(SwissProt)	and	Arabadopsis	
thaliana	(UniProt)	databases.	
	
2.5. Ubiquitin	cross-linking	assay	
The	cross-linking	assay	contained	0.75	µM	mE1,	20	µM	E2-25K,	and	1.2	µM	Ubiquitin.	
Reactions	were	performed	in	250	mM	Tris-HCl	pH	8.0,	25	mM	MgCl2,	2.5	mM	ATP,	1	
mM	 DTT,	 50	 mM	 Creatine	 Phosphate	 (Roche,	 0621714001),	 3	 U/mL	 inorganic	
pyrophospatase	(Sigma,	I1643),	and	3	U/mL	Creatine	phosphokinase	(Sigma,	C3755).	
35	mM	 NaCl	 and	 35	mM	 NaHCO3	 pH	 8.0	 were	 added	 to	 the	 appropriate	 assays.	
Reactions	 were	 carried	 out	 in	 a	 final	 volume	 of	 50	 μL	 at	 37oC	 for	 15	 minutes,	
terminated	by	the	addition	of	1	mM	EDTA	and	reducing	the	temperature	to	4oC	for	15	
minutes.	Samples	were	resolved	by	SDS-PAGE	following	incubation	with	non-reducing	
Laemmli	buffer	for	20	minutes.	 	
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3. Results	
When	CO2	interacts	with	uncharged	Ne-amine	groups	of	lysine	residues	a	carbamate	
is	generated,	which	changes	the	electrostatic	properties	of	the	protein	(Lorimer	and	
Miziorko,	 1980).	 Ubiquitin	 is	 a	 small	 (~8	 kDa)	 protein	 involved	 in	 a	 wide	 array	 of	
signalling	process.	The	diverse	range	of	signalling	pathways	influenced	by	ubiquitin	is	
only	possible	because	of	the	many	different	combinations	of	ubiquitin	crosslinking	to	
form	 various	 polyubiquitin	 chains	 (Zinngrebe	 et	 al.,	 2014).	 Polyubiquitin	 chain	
synthesis	 requires	 isopeptide	 bond	 formation	 between	 Ne-amine	 groups	 of	 lysine	
residues	and	the	C-terminal	glycine	of	the	next	ubiquitin.	PTMs,	such	as	acetylation	
and	 phosphorylation,	 are	 known	 to	 impact	 on	 the	 rate	 of	 polyubiquitin	 chain	
formation	(Ohtake	et	al.,	2015;	Wauer	et	al.,	2015).	Therefore,	the	overall	hypothesis	
of	this	work	is	that	CO2	binds	directly	with	Ne-lysine	of	ubiquitin	to	confer	a	biological	
signal	modulating	the	rate	of	polyubiquitin	chain	formation.	The	initial	aims	were	to	
identify	sites	of	CO2-dependent	carbamylation	of	ubiquitin	and	consequently	to	define	
a	change	in	function	associated	with	the	PTM.	Here,	MALDI-TOF	(hereafter	referred	
to	simply	as	MALDI)	and	LC-MS	investigations	prove	that	K33	and	K48	of	ubiquitin	are	
sites	 of	 CO2-dependent	 carbamylation.	 This	 is	 followed	 by	 an	 in	 vitro	 cross-linking	
assay	that	suggests	carbamate	formation	reduces	the	rate	of	ubiquitin	discharge	from	
its	E2	ligase,	which	provides	a	mechanism	to	support	the	overall	hypothesis.	
3.1. Recombinant	protein	expression	
Recombinant	A.	thaliana	and	H.	sapiens	His6-ubiquitin	were	expressed	 in	Rosetta	2	
pLysS	and	BL21	(DE3)	cells,	 respectively,	and	purified	by	 immobilized	metal	affinity	
chromatography	 (IMAC)	 (Figure	 3.1.A,	 B,	 respectively).	 These	 proteins	 have	 high	
sequence	similarity	(Figure	3.1.G)	and	were	deemed	to	be	greater	than	95	%	pure	by	
densitometry	 (data	 not	 shown).	 For	 both	 ubiquitin	 samples	 fractions	 1	 –	 5	 were	
pooled	and	concentrated	for	use	in	MS	investigations	and	in	vitro	crosslinking	assays.	
His6-mE1	was	expressed	in	BL21	(DE3)	and	purified	by	IMAC	(Figure	3.1.C).	The	three	
elution	 fractions	 were	 pooled,	 concentrated	 and	 purified	 by	 AEC	 (Figure	 3.1.C).	
Fractions	 corresponding	 to	 Fig	 1.C	 lanes	 6	 and	 7	 were	 further	 purified	 by	 SEC	
(Figure	3.1.D).	These	fractions	were	determined	to	be	>	98	%	pure	by	densitometry	
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and	were	pooled	and	concentrated	for	us	in	in	vitro	crosslinking	assays.	GST-E2-25K	
was	 expressed	 in	 Rosetta	 (DE3)	 pLysS	 and	 purified	 by	 affinity	 chromatography	
(Figure	3.1.E).	GST-E2-25K	was	further	purified	by	SEC	(Figure	3.1.F),	with	 fractions	
corresponding	to	lanes	2-11	pooled	and	concentrated	for	use	in	in	vitro	crosslinking	
assays.	
	
Figure	 3.1|	 Recombinant	 protein	 expression	 resolved	 by	 SDS-PAGE.	 A)	 Ni2+	 NTA	 purification	 of	 A.	
thaliana	ubiquitin.	Lanes	1	–	5:		50	–	250	mM	imidazole	elutions,	respectively.	B)	Ni2+	NTA	purification	
of	H.	sapiens	ubiquitin.	Lanes	1	–	5:	50	–	250	mM	imidazole	elutions,	respectively.	Lanes	6	–	8:	1	M	
imidazole	fraction,	pooled	and	concentrated	fractions	1	–	5,	and	insoluble	fraction,	respectively.	C)	mE1	
purification.	Lanes	1	–	4:	final	wash	and	3x	100	mM	elutions.	Lanes	5	–	7:	AEC	fractions.	D)	Lanes	1	–	5:	
mE1	SEC	fractions.	E)	GST-E2-25K	purification.	Lane	1-2:	 final	wash	fraction	and	10	mM	glutathione	
elution,	respectively.	F)	GST-E2-25K	SEC	fractions.	Lanes	2	–	12	(inclusive)	were	pooled	for	future	use.	
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G)	 sequences	 of	 A.	 thaliana	 and	 H.	 sapiens	 ubiquitin.	 Lysine	 residues	 are	 highlighted	 in	 bold	 red	
typeface	 and	 their	 position	 is	 annotated.	 Differing	 residues	 are	 highlighted	 in	 green	 underlined	
typeface.	
3.2. Confirmation	of	Trapped	Carbamates	using	TEO	by	detection	with	MALDI-
TOF	
Carbamates	 are	 labile	 and	 thus	 their	 identification	 by	 MS	 remains	 a	 technical	
challenge.	 Recently,	 a	 method	 to	 trap	 carbamates	 with	 an	 alkylating	 reagent,	
triethyloxonium	tetrafluoroborate	(TEO),	has	been	developed	in	which	carboxylic	acid	
groups	 are	 ethylated,	 introducing	 a	 modification	 with	 a	 mass	 of	 28.0303	 Da	
(Linthwaite,	2016).	A	trapped	carbamate	is	recognised	as	a	carboxyethyl	modification,	
which	has	a	mass	of	72.0211	Da.	This	modification	is	stable	and	can	be	detected	by	
MS	after	the	protein	has	been	digested	by	trypsin.	MALDI	is	a	quick,	low	cost	form	of	
MS	 that	 rapidly	 identifies	 peptides.	 Since	 the	 mass	 of	 a	 peptide	 modified	 by	 the	
reaction	 with	 TEO	 can	 be	 calculated,	 the	 hypothesis	 of	 this	 investigation	 is	 that	
carboxyethylated	peptides	can	be	detected	by	MALDI.	
	
The	trapping	experiment	was	performed	using	recombinant	A.	thaliana	and	H.	sapiens	
Ubiquitin	in	solution	with	20	mM	NaHCO3	pH	7.4	and	a	molar	excess	of	TEO.	This	was	
followed	by	tryptic	digest	and	the	resulting	peptides	were	analysed	by	MALDI.	Given	
that	MALDI	measures	peptides	by	mass,	a	key	question	 is	how	can	a	distinction	be	
made	 between	 a	 carboxyethylated	 peptide	 and	 a	 random	 isobaric	 peptide?	 The	
solution	 to	 this	 problem	 can	 be	 found	 by	 searching	 for	 an	 ethylation	 series	
corresponding	 to	 the	peptide	of	 interest.	An	ethylation	series	 is	generated	when	a	
protein	is	differentially	ethylated	during	the	reaction	with	TEO.	Following	trypsinolysis,	
this	gives	 rise	 to	a	number	of	detected	peptides	 increasing	by	28.0303	Da	 (i.e.	 the	
mass	 of	 an	 ethylation).	 Therefore,	 ethylation	 series	 are	 a	 positive	 control	 to	
demonstrate	the	reaction	with	TEO	has	taken	place	on	the	peptide	of	interest.	If	the	
peptide	of	interest	has	a	72.0211	Da	modification	within	an	ethylation	series,	it	can	
be	deduced	that	this	is	an	ethylated	carbamate.	An	ethylation	series	was	obtained	for	
	
37	
two	peptides	of	ubiquitin,	43LIFAGKQLEDGR54	and	30IQDKEGIPPDQQR42	(Table	3.1	and	
3.2,	respectively).	
Table	 3.1|	 Ethylation	 series	 of	 tryptic	 digest	 peptide	 corresponding	 to	 carboxyethylation	 of	 K48	 of	
ubiquitin.	Only	peptides	with	K48	miscleavage	are	considered.	The	predicted	mass	is	accurate	±	0.5	Da.	
Et	=	ethylation,	Ce	=	carboxyethylation.	
43LIFAGKQLEDGR54	
Predicted	mass	 Detected	Peptide	Mass	 Modification	
1346.74272	 -	 -	
1374.77402	 1374.753174	 Et	
1402.80532	 1402.781738	 2x	Et	
1418.76382	 1418.723389	 Ce	
1446.79512	 1446.714722	 Ce,	Et	
1474.82642	 -	 Ce,	2x	Et	
	
It	was	hypothesised	that	carboxyethylated	peptides	could	be	identified	by	MALDI-TOF.	
It	is	possible	to	infer	the	existence	of	such	peptides	by	delineating	the	ethylation	series	
of	 the	peptide.	Using	 this	 approach,	 a	 1418.723	Da	peptide	was	 confirmed	as	 the	
carboxyethyl	peptide	corresponding	to	 43LIFAGK(Ce)QLEDGR54	(table	3.1).	A	second	
carboxyethylated	peptide	was	detected	as	part	of	an	ethylation	series	with	a	1595.799	
Da	mass	 that	 corresponds	 to	 30IQDK(Ce)EGIPPDQQR42	 (table	3.2).	 These	ethylation	
series	are	a	strong	indicator	that	the	carboxyethyl	peptides	were	derived	downstream	
of	the	reaction	with	TEO	and	it	can	thus	be	accepted	that	carboxyethylated	peptides	
can	be	detected	by	MALDI.	
Table	 3.2|	 Ethylation	 series	 of	 tryptic	 digest	 peptide	 corresponding	 to	 carboxyethylation	 of	 K33	 of	
ubiquitin.	The	predicted	mass	is	accurate	±	0.5	Da.	Et	=	ethylation,	Ce	=	carboxyethylation.	
30IQDKEGIPPDQQR42	
Predicted	mass	 Detected	Peptide	Mass	 Modification	
1523.78129	 1523.763428	 -	
1551.81259	 1551.792236	 Et	
1579.84389	 1579.82312	 2x	Et	
1595.80239	 1595.79895	 Ce	
1623.83369	 1623.817383	 Ce,	Et	
1651.86499	 -	 Ce,	2x	Et	
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Other	 peptides	with	 a	mass	 corresponding	 to	 carboxyethyl	modification	were	 also	
identified	(Table	3.3).	However,	an	ethylation	series	could	not	be	derived	for	these	
peptides.	 Therefore,	 it	 is	not	possible	 to	 confirm	 the	presence	of	 the	carboxyethyl	
modification	as	a	direct	result	of	the	trapping	reaction	with	TEO.		
Table	 3.3|	 Peptides	 of	 interest	 detected	 by	MALDI	 without	 a	 corresponding	 ethylation	 series.	 The	
predicted	mass	is	accurate	±	0.5	Da.	Et	=	ethylation,	Ce	=	carboxyethylation.	
Sequence	 Predicted	Peptide	Mass	 Detected	Peptide	Mass	 Modification	
12TITLEVEPSDTIENVKAK29	 2059.08052	 2059.023193	 Ce	
28AKIQDKEGIPPDQQR42	 1822.96578	 1822.954	 Ce,	Et	
28AKIQDKEGIPPDQQR42	 1850.99706	 1850.976	 Ce,	2x	Et	
55TLSDYNIQKESTLHLVLR72	 2225.20678	 2225.098145	 Ce,	Et	
	
The	 aim	 of	 this	 investigation	 was	 to	 identify	 peptides	 with	 the	 carboxyethyl	
modification	 indicative	 of	 a	 trapped	 carbamate.	 Identification	 of	 a	 peptide	 was	
achieved	by	comparing	predictive	mass	with	the	mass	of	peptides	detected	by	MALDI.	
If	 a	 suspected	 carboxyethylated	 peptide	 is	 detected	 and	 found	 to	 have	 a	
corresponding	ethylation	series	it	can	be	concluded	that	a	carboxyethyl	modification	
was	 likely	 derived	 from	 the	 trapping	 reaction	with	 TEO.	 However,	 if	 an	 ethylation	
series	does	not	exist	the	most	likely	explanation	is	that	an	isobaric	peptide	was	actually	
detected.	In	this	investigation	two	peptides,	corresponding	to	carboxyethylated	L43-
R54	and	I30-R42,	were	identified	concurrently	with	respective	ethylation	series.	This	
confirms	the	initial	hypothesis	and	therefore,	the	aim	of	this	investigation	has	been	
achieved.	
	
3.3. Confirmation	of	Ubiquitin	carboxyethyl	modification	at	K33	and	K48	by	
LC-MS	
In	 the	 previous	 investigation,	 it	was	 demonstrated	 that	 carboxyethylated	 peptides	
could	 be	 detected	 and	 confirmed	 by	MALDI	 and	 an	 ethylation	 series,	 respectively	
(Chapter	3.1).	This	confirms	 the	 trapping	 reaction	with	TEO	occurred	but	does	not	
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provide	 accurate	 information	 regarding	 the	 modified	 residue.	 Consequently,	 this	
investigation	aims	to	identify	the	specific	site	of	modification	in	the	peptide	sequence.	
It	 is	known	that	carbamates	are	formed	at	uncharged	Ne-amino	groups.	Therefore,	
the	hypothesis	of	this	investigation	is	that	carboxyethyl	modifications	occur	at	lysine	
residues.	 The	 trapping	 reaction	 was	 performed	 with	 both	A.	 thaliana	 and	 human	
recombinant	ubiquitin.	Following	tryptic	digest,	peptides	were	resolved	by	LC-MS/MS	
and	the	MS2	data	was	compared	with	the	corresponding	Uniprot	proteome	databases	
using	X!Tandem.	Using	this	approach	it	was	confirmed	that	K33	and	K48	are	sites	of	
carboxyethyl	modification.	
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Table	3.4|	Ubiquitin	peptides	identified	with	carboxyethyl	modification.	Ce	=	carboxyethylation,	Et	=	
Ethylation.	
Organism	 Peptide	 Modifications	
Identified	
m+h	by	LC-
MS/MS	
Log(e)	
False	
Positive	
A.	
thaliana	
7TLTGKTKVLEVESSDTIDNVK27	 K11Ce,	E18Et	 2377.27080	 -3.4	 √	
7TLTGKTKVLEVESSDTIDNVK27	 K13Ce	 2349.23950	 -4.4	 √	
28AKIQDKEGIPPDQQR42	 K29Ce	 1794.93448	 -6.5	 √	
28AKIQDKEGIPPDQQR42	 K29Ce,	D32Et	 1822.96578	 -4.9	 √	
28AKIQDKEGIPPDQQR42	 K29Ce,	D39Et	 1794.960	 -4.2	 √	
28AKIQDKEGIPPDQQR42	
K29Ce,	D32Et,	
E34Et	
1850.99706	 -3.7	 √	
30IQDKEGIPPDQQR42	 K33Ce	 1595.80237	 -5.8	 	
28AKIQDKEGIPPDQQR42	 K33Ce	 1794.93448	 -4.7	 √	
30IQDKEGIPPDQQR42	 K33Ce,	E34Et	 1623.83367	 -5.6	 	
43LIFAGKQLEDGR54	 K48Ce	 1418.76378	 -3.3	 	
43LIFAGKQLEDGR54	 K48Ce,	E51Et	 1446.79508	 -4.0	 	
H.	
sapiens	
28AKIQDKEGIPPDQQR42	 K29Ce,	D32Et	 1822.96575	 -5.5	 √	
28AKIQDKEGIPPDQQR42	
K29Ce,	D32Et,	
E34Et	
1850.99705	 -3.1	 √	
30IQDKEGIPPDQQR42	 K33Ce	 1595.80237	 -4.7	 	
30IQDKEGIPPDQQR42	 K33Ce,	E34Et	 1623.83367	 -4.5	 	
43LIFAGKQLEDGR54	 K48Ce	 1418.76378	 -3.3	 	
43LIFAGKQLEDGR54	 K48Ce,	E51Et	 1446.79510	 -4.5	 	
43LIFAGKQLEDGR54	 K48Ce,	E51Et	 1432.77945	 -5.8	 	
	
The	hypothesis	of	this	investigation	is	that	carboxyethyl	modifications	occur	at	Lysine	
residues	 in	the	ubiquitin	sequence.	Using	LC-MS/MS	paired	with	X!Tandem	protein	
identification	software	enabled	the	identification	of	carboxyethyl	(72.	0211	Da)	and	
ethyl	(28.0313	Da)	modifications	to	specific	residues	along	peptide	sequences.	This	
approach	 resulted	 in	 11	 and	7	 carboxyethyl	modified	 peptides	 for	A.	 thaliana	 and	
human	 ubiquitin,	 respectively	 (Table	 3.4).	 Not	 all	 the	 carboxyethyl	 modifications	
recorded	 are	 true	 positives.	 This	 is	 demonstrated	 in	 figure	 3.1,	 where	 manual	
inspection	of	the	fragmentation	pattern	clearly	demonstrates	there	are	no	matched	
peptides	for	fragments	that	include	the	lysine	reported	to	be	carboxyethyl	modified.	
This	 indicates	 a	weak	 correlation	between	 the	detected	peptide	 and	 the	database	
entry.	In	addition	to	this	the	peptide	is	matched	with	the	gene	product	of	A.	thaliana	
UBQ12,	which	has	a	lysine	residue	at	position	13	of	its	sequence	(figure	3.1).	This	is	
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clearly	 incorrect	 because	 recombinant	 ubiquitin	 was	 generated	 from	 A.	 thaliana	
UBQ11	or	human	UBC	gene,	which	have	an	isoleucine	residue	at	this	position.	These	
are	examples	of	how	the	software	can	assign	the	detected	mass	to	a	peptide	in	the	
database	to	generate	a	false	positive.	Therefore	it	is	imperative	to	manually	inspect	
each	MS2	data	in	order	to	validate	the	assigned	peptide	is	a	true	positive.	In	addition	
to	matched	fragments,	the	log(e)	score,	which	is	the	likelihood	of	the	peptide	being	
matched	with	a	random	peptide,	is	a	good	indicator	of	the	accurate	assignment	of	a	
detected	peptide	to	a	peptide	in	the	database.	The	lower	the	log(e)	score	the	higher	
the	 confidence	 in	 the	 assignment.	 This	 approach	 was	 used	 to	 assess	 the	 results	
generated	by	X!Tandem	peptide	assignment	(table	3.4).	
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Figure	3.2|	Peptide	fragmentation	pattern	corresponding	to	carboxyethyl	modification	at	a)	K11	and	b)	
K13.	Complete	list	of	modifications,	mutations,	and	miscleavage	events	are	stated	in	upper	left	corner.	
Matched	y	ions	are	listed	in	red.	
	
Two	lysine	residues	that	were	identified	by	LC-MS/MS	for	carboxyethyl	modification	
are	likely	true	positives,	K33	and	K48.	Using	the	aforementioned	approach	for	manual	
inspection	 of	 the	 MS2	 data,	 it	 is	 clear	 that	 carboxyethyl	 K33	 has	 been	 correctly	
assigned	(Figure	3.2).	The	fragmentation	pattern	shows	matched	peptides	throughout	
the	entire	peptide	sequence	and	the	log(e)	score	is	good.	Moreover,	the	peptides	are	
also	present	with	multiple	ethylations,	which	is	consistent	with	the	data	from	chapter	
3.1.	Therefore,	K33	can	be	accepted	as	a	site	of	carboxyethyl	modification.	
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The	peptide	corresponding	to	carboxyethyl	K48	also	has	a	 thorough	fragmentation	
pattern	combined	with	a	good	log(e)	score	(Figure	3.3).	This	peptide	is	also	observed	
with	ethylations,	which	was	expected	based	on	the	results	using	MALDI	(chapter	3.1).	
Therefore	K48	can	also	be	accepted	as	a	site	of	carboxyethyl	modification.	
	
	
Figure	3.3|	Peptide	fragmentation	pattern	corresponding	to	carboxyethyl	modification	at	K33	of	human	
ubiquitin.	a)	K33	carboxyethyl	modification.	b)	K33	carboxyethylation	with	ethylation	at	E34.	Matched	
y	ions	are	listed	in	red.	
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LC-MS/MS	is	a	powerful	tool	for	assigning	the	amino	acid	specific	site	of	PTMs.	Here,	
the	importance	of	manually	inspecting	the	MS2	data	was	highlighted	in	order	to	avoid	
accepting	false	positive	results.	From	this	it	could	also	be	confirmed	that	K33	and	K48	
are	sites	of	carboxyethyl	modification	along	the	ubiquitin	sequence.	This	is	consistent	
with	the	results	from	the	MALDI	investigation	and	has	enabled	the	specific	modified	
residues	 to	 be	 defined.	 The	 results	 also	 demonstrate	 a	 consistency	 for	 sites	 of	
carboxyethyl	 modification	 between	 plant	 and	 human	 ubiquitin.	 Therefore	 the	
hypothesis	of	this	investigation,	that	carboxyethyl	modification	of	ubiquitin	occurs	at	
lysine	 residues,	 can	 be	 confirmed.	 Moreover	 it	 has	 been	 demonstrated	 that	 this	
modification	specifically	occurs	at	only	two	lysine	residues.	
	
	
Figure	 3.4|	 Peptide	 fragmentation	 pattern	 corresponding	 to	 peptides	 containing	 carboxyethyl	
modification	of	 K48.	 Complete	 list	 of	modifications	 are	 stated	 in	 upper	 left	 corner.	 Predicted	 y	 ion	
masses	are	listed	with	matched	detected	peptides	in	red.	
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3.4. Ubiquitin	carboxyethyl	modification	is	CO2-dependent	
In	 the	 previous	 investigation,	 it	 was	 demonstrated	 that	 K33	 and	 K48	 are	 sites	 of	
carboxyethyl	 modification	 (Chapter	 3.2).	 Although	 this	 modification	 has	 a	 mass	
corresponding	 to	 a	 trapped	 carbamate,	 it	 has	 not	 been	 confirmed	 that	 the	
modification	 is	 CO2-dependent.	 NMR	 studies	 utilise	
13C	 supplemented	 media	 to	
demonstrate	 formation	 of	 carbamate	 adducts	 from	 CO2.	 It	 was	 therefore	
hypothesised	that	13C	could	be	used	to	confirm	the	carboxyethyl	modification	is	a	CO2-
derived	carbamate	trapped	by	reaction	with	TEO.	To	achieve	this	the	trapping	reaction	
is	 supplemented	with	NaH13CO3,	which	will	 readily	 dissociate	 to	 form	
13CO2	and	 is	
subsequently	ethylated	during	the	reaction	with	TEO.	Consequently,	the	carboxyethyl	
modification	has	a	mass	of	73.0244	Da.	Subsequently,	 the	peptides	containing	K33	
and	K48	were	confirmed	as	sites	of	CO2-dependent	carboxyethyl	modification.		
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Figure	 3.5|	 13C	 peptide	 fragmentation	 patterns	 corresponding	 to	 CO2-dependent	 carboxyethyl	
modification	of	ubiquitin.	a)	carboxyethyl	modification	at	K33.	b)	Carboxyethyl	modification	at	K33	with	
ethylation	at	E34.	c)	Carboxyethyl	modification	at	K48	with	ethylation	at	E51.	Predicted	y	ion	masses	
are	listed	with	matched	detected	peptides	in	red.	Ce=Carboxyethylation,	Et=Ethylation	
	
The	 aim	 of	 this	 investigation	 was	 to	 use	 13C	 to	 demonstrate	 the	 carboxyethyl	
modification	 is	CO2-dependent.	 The	 trapping	 reaction	was	performed	with	20	mM	
NaH13CO3,	which	was	theorised	to	yield	a	carboxyethyl	modification	with	a	+1	Da	shift	
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from	 that	 of	 the	 12C	 investigations.	 This	 resulted	 in	 identification	 of	 the	 peptides	
corresponding	to	carboxyethyl	K33	and	K48	(Figure	3.4).	There	is	no	matched	peptide	
for	the	y	ion	of	carboxyethyl	K33	(Figure	3.4.A)	but	this	is	present	for	the	peptide	that	
includes	ethylation	at	E34	(Figure	3.4.B).	Despite	this,	the	N	terminal	fragments	(i.e.	
fragments	 including	 the	 carboxyethyl	 lysine	 residue)	 are	 matched	 y	 ions.	 This,	
combined	with	log(e)	scores	of	-3.7	and	-2.3,	provides	evidence	in	favour	of	a	trapped	
CO2-dependent	carbamate	at	K33	of	ubiquitin.	In	addition,	the	fragmentation	patterns	
for	 carboxyethyl	 K48	 contains	 matched	 peptides	 including	 and	 surrounding	 the	
modified	lysine.	This	MS2	data	has	a	log(e)	score	of	-3.2,	suggesting	the	carboxyethyl	
modification	is	due	to	a	trapped	CO2-dependent	carbamate.	
	
	
Figure	 3.6|	 MaxQuant	 MS2	 data	 for	 13C	 carboxyethyl	 a)	 K33	 and	 b)	 K48	 indicating	 carboxyethyl	
modification	on	the	y10	and	y7	ions,	respectively.	
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Different	software	packages	use	alternative	algorithms	to	assign	a	peptide	mass	to	an	
entry	 in	 the	 proteome	 database.	 By	 using	 multiple	 software	 packages	 greater	
confidence	can	be	achieved	for	peptides	that	have	been	matched	with	the	differing	
algorithms.	Consequently,	the	13C	data	was	also	processed	in	MaxQuant	(Figure	3.5).	
This	clearly	shows	matched	peptides	for	the	y	ions	of	the	carboxyethylated	K33	and	
K48.	In	addition	the	high	scores	(117.09	and	138.66	for	K33	and	K48,	respectively),	
provide	 greater	 confidence	 that	 these	 results	 are	 not	 due	 to	 chance,	 which	 is	
consistent	 with	 the	 results	 generated	 in	 X!Tandem.	 Modification	 of	 these	 lysine	
residues	with	a	73.0244	Da	adduct	requires	the	incorporation	of	a	13CO2	(44.9941	Da)	
and	its	alkylation	during	the	trapping	reaction,	resulting	in	an	additional	ethyl	(28.0303	
Da)	 to	 this	 adduct.	 The	 reaction	mixture	was	 supplemented	with	NaH13CO3,	which	
dissociated	to	form	13CO2.	This,	in	turn,	enabled	the	labile	carbamate	to	form	on	these	
lysine	residues.	When	compared	to	the	trapping	experiment	using	12C,	the	expected	
+	1.0033	Da	mass	 shift	 of	 the	modification,	 corresponding	 to	 the	different	 carbon	
isotopes,	is	observed.	Moreover,	the	13C	modification	is	only	observed	at	the	residues	
previously	 identified	 as	 sites	 of	 ubiquitin	 carboxyethyl	 formation.	 Altogether,	 this	
investigation	proved	that	the	carboxyethyl	modifications	identified	at	K33	and	K48	are	
due	to	carbamate	formation	derived	from	CO2.	
	
3.5. CO2	inhibits	ubiquitin	discharge	from	E2	ligase.	
The	MS	experiments	have	confirmed	that	CO2	interacts	with	K33	and	K48	of	ubiquitin.	
However,	 the	 physiological	 significance	 of	 this	 interaction	 requires	 elucidation.	
Polyubiquitin	chains	are	generated	by	the	formation	of	isopeptide	bonds	between	the	
Ne-Lysine	 on	 the	 substrate	 protein	 or	 ubiquitin	 and	 the	 carboxyl	 group	 of	 the	 C-
terminal	glycine	residue	of	the	next	ubiquitin.	Formation	of	a	carbamate	reverses	the	
charge	 status	 of	 the	 Ne-amine	 group	 on	 lysine	 residues.	 Therefore,	 it	 was	
hypothesised	 that	 physiologically	 high	 CO2	 concentration	 will	 reduce	 the	 rate	 of	
polyubiqutin	chain	formation.		
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To	test	this	hypothesis	a	previously	established	cross	linking	protocol	was	adapted	and	
performed	in	the	presence	of	35	mM	NaHCO3	(Pickart	and	Raasi,	2005).	Upon	NaHCO3	
dissociation	this	equates	to	~2	mM	CO2,	which	is	observed	in	patients	with	chronic	
hypercapnia*.	Under	these	conditions	there	are	two	mass	shifts	of	the	E2	ligase	that	
correspond	to	the	addition	of	mono-	and	di-ubiquitin	chains	(Figure	3.6).	This	effect	is	
independent	 of	 increased	 cation	 concentration	 and	 boiling	 samples	 introduced	
protein	bands	at	~45	kDa.	It	is	thought	that	these	are	artefactual	polyubiquitin	chains	
that	cross	link	upon	boiling	(Pickart	and	Raasi,	2005).	
	
	
Figure	3.7|	Ubiquitin~E2	discharge	 is	perturbed	by	2	mM	CO2.	Ubiquitin	discharge	from	E2	 ligase	 is	
perturbed	 upon	 addition	 of	 35	 mM	 NaHCO3,	 which	 dissociates	 to	 ~2	 mM	 CO2	 at	 pH	 7.5	 and	 is	
independent	of	an	increase	in	cation	concentration.	Resolved	by	SDS-PAGE,	left	four	lanes	represent	
boiled	samples	in	Laemmli	buffer.	Right	hand	lanes	represent	samples	incubated	in	Laemmli	buffer	at	
room	temperature.	Mass	shifts	observed	are	due	to	*)	mono-ubiquitin	and	**)	di-ubiquitin.	n	=	1.	
	
Under	 conditions	 representing	 physiological	 hypercapnia	 there	 is	 a	 significant	
decrease	 in	 ubiquitin	 discharge	 from	 E2-25K	 (Figure	 3.6).	 This	 resulted	 in	 the	
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formation	of	E2~Ub	conjugates	that	are	also	observed	by	other	groups	investigating	
ubiquitylation	kinetics	(Buetow	et	al.,	2015;	Das	et	al.,	2009;	Saha	et	al.,	2011).	This	
suggests	that	carbamate	formation	at	K48	disrupts	ubiquitin	discharge	in	a	manner	
analogous	 to	 mutations	 that	 disrupt	 the	 stabilising	 interactions	 between	 E2	 and	
Ubiquitin	(Saha	et	al.,	2011).	Of	note,	none	of	these	investigations	report	perturbed	
discharge	of	di-ubiquitin.	This	is	because	they	perform	experiments	with	a	substrate	
protein	whereas	the	experimental	set	up	here	does	not.	It	will	be	necessary	to	perform	
a	similar	experiment	and	demonstrate	that	a)	the	rate	of	polyubiqutin	chain	formation	
is	 reduced,	 b)	 the	 effect	 of	 perturbed	 ubiquitin	 discharge	 is	 dose-dependent,	 c)	
carbamate	stoichiometry	correlates	with	the	dose	response,	and	d)	the	same	effect	is	
observed	with	K33.	This	information	will	prove	useful	when	attempting	to	determine	
a	 physiologically	 relevant	 role	 for	 CO2-dependent	 ubiquitin	 carbamylation.	 One	
possible	 role	 for	 this	 phenomenon	 is	 the	 reduction	 of	 proteasomal	 activity.	 The	
proteasome	 is	 a	 large	 complex	 that	 degrades	 proteins	 tagged	 with	 polyubiquitin	
chains.	It	has	been	demonstrated	that	substrate	proteins	tagged	with	tetraubiquitin	
chains	 are	 preferentially	 degraded	 by	 the	 proteasome	 (Singh	 et	 al.,	 2016).	 CO2-
mediated	 carbamate	 formation	 on	 K33	 and	 K48	 may	 reduce	 the	 activity	 of	 the	
proteasome	by	reducing	ubiquitylation	kinetics.	
	
3.6. Conclusion	of	results	
Here	 it	 has	 been	 demonstrated	 that	 K33	 and	 K48	 are	 sites	 of	 CO2-dependent	
carbamate	formation	on	ubiquitin.	The	use	of	TEO	enabled	the	labile	carbamate	to	be	
trapped	and	readily	identified	by	MS.	MALDI-TOF	was	originally	used	to	confirm	the	
presence	of	carboxyethylated	peptides	as	part	of	an	ethylation	series	before	MS/MS	
data	revealed	the	site	of	modification.	Subsequently	a	13C	 investigation	proved	the	
modification	 is	 due	 to	 CO2-dependent	 carbamate	 formation.	 This	 resulted	 in	 the	
conclusive	 assignment	 of	 K33	 and	 K48	 as	 sites	 of	 CO2-mediated	 carbamylation.	
Despite	this,	a	physiological	role	for	this	PTM	has	not	yet	been	elucidated.	However,	
initial	 investigations	 suggest	 carbamate	 formation	 reduces	 the	 rate	 of	 ubiquitin	
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discharge.	Chapter	4	contains	a	more	detailed	discussion	of	these	results	and	includes	
suggestions	of	future	research.	 	
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4. Discussion	
CO2	has	been	demonstrated	to	have	a	signalling	role	in	normal	biological	processes	
and	 disease	 (Cummins,	 2017;	 Cummins	 and	 Keogh,	 2016).	 CO2	 can	 interact	 with	
protein	at	uncharged	amine	groups	 to	 form	a	 labile	 covalent	modification	 called	a	
carbamate	(Ewing	et	al.,	1980).	This	modification	introduces	a	change	of	charge	status	
that	may	have	profound	effects	on	protein	interactions	(Terrier	and	Douglas,	2010)	or	
enable	metal	 chelation	 for	 enzyme	 function	 (Lorimer	 et	 al.,	 1976).	 An	 alternative	
method	for	the	stabilisation	of	carbamates	is	achieved	by	the	positioning	of	positively	
charged	residues	in	close	proximity	to	the	lysine	residue	interacting	with	CO2	(Meigh	
et	 al.,	 2013).	 Thus,	 carbamate	 formation	 is	 known	 to	 exert	 an	 influence	 on	 the	
structure,	function	and	activity	of	several	proteins.	Despite	this,	the	number	of	known	
proteins	to	interact	with	CO2	via	carbamate	formation	is	relatively	low.	This	is	largely	
due	 to	 the	 labile	 nature	 of	 carbamates	 preventing	 their	 identification	 by	 high	
throughput	 techniques.	 Therefore,	 the	emphasis	 of	 previous	 research	has	been	 to	
identify	effectors	of	CO2-mediated	signalling	processes.	The	aim	of	this	project	was	to	
identify	a	signalling	molecule	sensitive	to	fluctuating	CO2	levels.	Previous	work	from	
this	research	group	suggested	ubiquitin	was	susceptible	to	carbamylation	and,	due	to	
its	 known	 role	 in	 cellular	 signalling,	 was	 selected	 as	 the	 focus	 of	 this	 project	
(Linthwaite,	2016).	
	
4.1. Mass	spectrometry	confirms	ubiquitin	is	carbamylated	at	K33	and	K48	
A	technique	has	been	previously	developed	to	enable	identification	of	carbamates	by	
MS	(Linthwaite,	2016).	This	involves	the	ethylation	of	acidic	residues	by	reaction	with	
the	alkylating	reagent	TEO,	which	traps	carbamates	onto	the	protein.	Since	glutamate	
and	aspartate	are	also	ethylated	by	the	reaction	with	TEO,	an	ethylation	series	will	be	
generated	 for	 each	 peptide.	 This	 is	 where	 a	 series	 of	 peptides	 are	 identified	
corresponding	 to	 all	 possible	 combinations	 of	 ethylation	 events,	 including	 the	
carboxyethyl	 modification	 indicative	 of	 the	 trapped	 carbamate.	 The	 initial	
investigation	 therefore	 aimed	 to	 verify	 carbamates	 that	 could	 be	 trapped	 and	
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identified	 by	MS	 using	MALDI-TOF.	 Two	 peptides	were	 identified	 to	 incorporate	 a	
mass	corresponding	to	a	carboxyethyl	modification	as	part	of	an	ethylation	series	on	
Asp	 and	Glu	 residues	within	 the	 peptide	 (Table	 3.1	 and	 Table	 3.2).	 This	 is	 a	 good	
indicator	of	the	peptide	containing	a	carboxyethylated	residue	but	it	does	not	confirm	
the	site	of	modification.		
	
LC	MS/MS	is	used	to	assign	PTM	localizations.	By	taking	this	approach	it	was	confirmed	
that	K33	and	K48	are	sites	of	carboxyethylation	on	ubiquitin,	along	with	 ruling	out	
false	positive	 results.	However,	 it	was	not	 formally	possible	 to	conclude	that	 these	
modifications	are	due	to	CO2.	Therefore,	an	experiment	was	performed	that	utilised	
13C	 to	 demonstrate	 the	modifications	 at	 K33	 and	 K48	 are	 CO2-dependent	 trapped	
carbamates.	 Whilst	 this	 confirmed	 K33	 and	 K48	 as	 sites	 of	 CO2	 interaction,	 the	
physiological	 relevance	 of	 this	 modification	 is	 not	 clear.	 A	 limitation	 of	 the	
experimental	setup	is	the	inability	to	quantify	the	relative	abundance	of	unmodified	
and	carboxyethylated	peptides.	This	is	complicated	by	carboxyethylation	resulting	in	
miscleavage	of	the	lysine	residue.	
	
Modification	of	ubiquitin	 lysine	residues	have	been	proposed	to	exert	 influence	on	
subsequent	ubiquitin	modifications,	 including	polyubiquitin	chain	synthesis	(Ohtake	
et	al.,	2015).	Here,	acetylation	of	K6	and	K48	are	proposed	to	repress	isopeptide	bond	
formation	between	ubiquitin	molecules	at	K11,	K48	and	K63.	The	inhibitory	effect	on	
polyubiquitin	chain	formation	is	proposed	to	be	due	to	the	hydrophobic	property	of	
the	acetyl	group	attenuating	interaction	with	ubiquitin	binding	proteins	including	the	
E2	and	E3	ligases	that	perform	chain	elongation	(Husnjak	and	Dikic,	2012;	Ohtake	et	
al.,	 2015).	 Since	 carbamylation	 reverses	 the	 charge	 status	 of	 lysine	 residues,	 it	 is	
possible	that	CO2	exerts	a	similar	effect	on	ubiquitin	crosslinking	to	that	of	acetylation.		
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4.2. Physiological	implications	of	ubiquitin	carbamylation	
Ubiquitin	 is	 an	 8	 kDa	 protein	 conserved	 throughout	 the	 eukaryotic	 kingdom.	 It	 is	
involved	in	a	variety	of	cellular	process	ranging	from	protein	tagging	for	degradation	
to	 signal	 transduction	 and	 DNA	 repair	 (Passmore	 and	 Barford,	 2004).	 A	 variety	 of	
factors	 influence	 the	process	mediated	by	ubiquitination:	ubiquitin	polymerisation,	
cross-linking	of	specified	lysine	residues,	ubiquitin	chain	branching	and	positioning	of	
ubiquitin	on	the	target	protein	(Sadowski	and	Sarcevic,	2010).	In	order	for	ubiquitin	to	
bind	 to	 its	 target	protein	a	 series	of	 reactions	occur	 that	 result	 in	 formation	of	an	
isopeptide	bond	between	the	ubiquitin	C-terminal	glycine	residue	(G76)	and	the	ε-
amine	group	of	a	lysine	residue	of	the	substrate	protein	(Pickart,	2001).	This	process	
requires	ATP	and	 is	 catalysed	by	E1,	E2,	and	E3	ubiquitin	 ligases	 (Finley	and	Chau,	
1991;	Jentsch,	1992).	A	protein	bearing	a	single	ubiquitin	molecule	is	relatively	stable,	
whilst	proteins	tagged	with	poly-ubiquitin	chains	are	often	rapidly	degraded	(Chau	et	
al.,	 1989;	Gregori	 et	 al.,	 1990;	 Singh	et	 al.,	 2016).	 K48-linked	poly-ubiquitin	 chains	
predominate	and	are	the	principle	signal	for	26S	proteasomal	degradation	(Chau	et	
al.,	 1989).	 However,	 ubiquitin	 contains	 7	 lysine	 residues	 and	 all	 of	 these	 may	 be	
utilised	for	poly-ubiquitin	chain	formation	along	with	the	N-terminal	methionine	(Peng	
et	al.,	2003).	Specificity	of	cross-linked	poly-ubiquitin	chains	is	accomplished	through	
particular	 E2/E3	 pairing	 and	 the	 proximal	 environment	 that	 surrounds	 the	 lysine	
residues	(Petroski	and	Deshaies,	2005;	Sadowski	and	Sarcevic,	2010).		
	
It	has	been	demonstrated	 that	K33	and	K48	are	 sites	of	 carbamylation.	K33	 linked	
ubiquitin	 is	 typically	 involved	 in	 non-proteolytic	 signalling	 processes.	However,	 the	
extent	of	signalling	performed	by	this	atypical	ubiquitin	chain	is	poorly	understood.	
Despite	 this,	 K33-linked	 ubiquitination	 has	 been	 implicated	 in	 the	 DNA	 damage	
response	(Elia	et	al.,	2015),	AMPK	signalling	(Al-Hakim	et	al.,	2008),	TCR	inactivation	
(Huang	et	al.,	2010;	Yang	et	al.,	2015),	repression	of	type	I	interferon	transcription	(Liu	
et	al.,	2018),	recruitment	to	the	pre-autophagosomal	phagophore	(Nibe	et	al.,	2018),	
and	post-golgi	trafficking	(Yuan	et	al.,	2014).	In	contrast	to	K33,	K48	linked	ubiquitin	is	
almost	exclusively	involved	in	targeting	substrate	proteins	for	degradation	by	the	26S	
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proteasome	(Thrower	et	al.,	2000).	It	is	not	yet	clear	how	carbamylation	of	K33	and	
K48	affects	these	processes.	
	
The	results	of	the	cross-linking	assay	suggest	carbamylation	of	K48	reduces	the	rate	
of	 ubiquitylation.	 This	 is	 consistent	 with	 previous	 findings	 that	 report	 reduced	
ubiquitin	kinetics	upon	destabilising	interactions	between	ubiquitin	and	E2/E3	ligases	
(Saha	 et	 al.,	 2011).	 However	 this	 is	 in	 contrast	 to	 a	 recent	 report	 of	 increased	
ubiquitylation	under	hypercapnic	conditions	(Gwoździńska	et	al.,	2017).	It	should	be	
noted,	however,	that	for	this	investigation	Nedd-4	was	used	for	ubiquitination	assays.	
Nedd-4	 is	 an	 E3	 ligase	 that	 specifically	 catalyses	 K63-linked	 polyubiquitin	 chains	
(Maspero	et	al.,	2013).	Since	carbamylation	was	only	seen	to	occur	at	K33	and	K48,	it	
is	 unlikely	 that	 hypercapnia	 would	 reduce	 K63-linked	 polyubiquitination.	 In	 fact,	
carbamate	formation	may	prevent	crosslinking	at	these	residues,	which	increases	the	
probability	of	crosslinking	at	the	remaining	lysine	residues	(Ohtake	et	al.,	2015).		
	
Due	to	the	reduced	rate	of	ubiquitination	it	would	be	anticipated	that	an	in	vivo	model	
would	 demonstrate	 reduced	 proteasomal	 activity.	 This	 is	 because	 proteins	 tagged	
with	smaller	ubiquitin	chains	are	more	stable	than	those	with	longer	chains	(Singh	et	
al.,	 2016).	Despite	 this,	 proteasomal	 activity	 has	 been	 reported	 to	 increase	 during	
hypercapnic	conditions	(Jaitovich	et	al.,	2015;	Ottenheijm	et	al.,	2006).	This	may	be	
explained	 by	 alternative	 CO2-sensitive	 signalling	 pathways.	 Increased	 cAMP	
concentrations	and	PKA	activation	are	both	mechanisms	through	which	proteasome	
phosphorylation	 is	 stimulated	 and	 this	 is	 correlated	 with	 enhanced	 proteasomal	
degradation	 (Lokireddy	 et	 al.,	 2015).	 It	 has	 previously	 been	 shown	 that	 elevated	
bicarbonate	 causes	 sAC	 to	 increase	 cAMP	 production	 and	 stimulate	 PKA	 activity	
(Lecuona	et	al.,	2013;	Townsend	et	al.,	2009).	Moreover,	proteasomal	inhibition	has	
been	reported	to	increase	ER	stress,	induce	aberrant	signalling	pathways	and	reduce	
Drosophila	 lifespan,	 with	 a	 compensatory	 mechanism	 afforded	 by	 increased	
autophagy	(Suraweera	et	al.,	2012;	Velentzas	et	al.,	2013).	This	provides	a	mechanism	
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through	which	 hypercapnia	mediates	 increased	 proteasome	 activity	 but	 questions	
remain	concerning	elevated	CO2	and	rates	of	ubiquitination.	
	
It	has	previously	been	reported	that	CO2	may	act	as	a	readout	for	metabolic	burden	
(Vadasz	et	al.,	2012).	Na+/K+	ATPase	activity	 is	 reported	 to	consume	up	to	40	%	of	
cellular	ATP	therefore	CO2-responsive	endocytosis	of	this	membrane	protein	provides	
transient	metabolic	relief	until	CO2	levels	return	to	normal	(Vadasz	et	al.,	2012;	Vadasz	
et	al.,	2007).	This	may	also	be	the	basis	of	an	evolutionary	conserved	CO2-responsive	
immune	suppression	(Helenius	et	al.,	2009).	Here	the	priority	of	the	cell	is	survival	to	
replication	 and	 reducing	metabolic	 burden.	 As	 previously	mentioned,	 proteasome	
activity	 is	non-redundant	(Suraweera	et	al.,	2012;	Velentzas	et	al.,	2013).	However,	
ubiquitylation,	 which	 costs	 ATP,	 is	 redundant	 since	 protein	 turnover	 by	 the	
proteasome	can	continue	on	previously	ubiquitinated	proteins.	Upon	return	to	basal	
CO2	levels	these	dampened	processes	return	to	normal	rates.	In	the	context	of	chronic	
hypercapnia	where	ubiquitylation	rates	are	reduced,	expression	of	chaperones	such	
as	 HSF1	 may	 maintain	 proteostasis	 (Lu	 et	 al.,	 2018).	 This	 provides	 a	 mechanism	
through	which	the	metabolic	burden	of	the	cell	can	be	reduced	without	compromising	
essential	homeostatic	mechanisms.	
	
The	 present	 study	 suggests	 K48-linked	 polyubiquitin	 chain	 formation	 would	 be	
decreased,	which	is	in	contrast	to	a	previously	published	report	that	found	K48-linked	
polyubiquitination	was	increased	under	hypercapnic	conditions	(Haegens	et	al.,	2012).	
Such	 contradictory	 reports	 are	 commonplace	 when	 investigating	 the	 effect	 of	
hypercapnia.	 For	 example,	 NFκB	 is	 reported	 to	 be	 activated	 under	 elevated	 CO2	
conditions	(Abolhassani	et	al.,	2009;	Oliver	et	al.,	2012)	but	other	findings	report	NFκB	
inactivation	(Contreras	et	al.,	2012;	Helenius	et	al.,	2009;	Takeshita	et	al.,	2003).	There	
are	also	contrasting	reports	of	p44/42	MAPK	activation	under	hypercapnic	conditions	
(Otulakowski	et	al.,	2014;	Welch	et	al.,	2010).	Thus,	it	is	not	surprising	that	the	results	
of	the	cross-linking	assay	suggest	an	alternate	role	for	carbamylated	ubiquitin	to	that	
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of	the	literature.	Further	research	is	required	to	better	understand	the	inconsistencies	
between	published	reports.	
	
4.3. Future	work	
4.3.1. Carbamate	stabilisation	and	Stoichiometry	
Carbamates	are	a	labile	modification	that	typically	require	some	form	of	stabilisation.	
This	 can	 be	 achieved	 through	 coordination	 of	 a	metal	 ion	 (Lorimer	 and	Miziorko,	
1980),	interaction	with	a	proximal	charged	amine	(Meigh	et	al.,	2013),	or	because	of	
the	proximal	environment	providing	a	suitable	pKa	for	carbamate	stability	(Jimenez-
Morales	et	al.,	2014).	It	is	not	known	which	of	these	is	responsible	for	stabilisation	of	
carbamates	at	K33	and	K48	of	ubiquitin,	although	 it	 is	unlikely	 that	a	carbamate	 is	
stabilised	 on	 ubiquitin	 through	 chelation	 of	 a	 metal	 ion.	 Structural	 studies	
investigating	 this	 will	 not	 only	 provide	 insights	 to	 the	 mechanism	 of	 carbamate	
stabilisation	 on	 ubiquitin	 but	 also	 to	 the	 general	 physicochemical	 properties	 of	
carbamate	formation.	This	will	impact	the	field	by	providing	better	predictive	tools	of	
proteins	susceptible	to	carbamylation.	
	
A	CO2	sensor	must	respond	to	fluctuating	levels	of	CO2.	In	order	to	understand	this	
process,	it	is	imperative	to	define	carbamate	stoichiometry	at	various	CO2	levels.	This	
could	be	achieved	 in	multiple	ways.	 Firstly,	 use	of	 an	 isobaric	 tag,	 such	as	TMT	or	
iTRAQ,	enables	 the	 relative	quantification	of	 carbamate	 formation	at	different	CO2	
concentrations.	 This	 approach	 has	 been	 applied	 to	 other	 PTMs,	 such	 as	
phosphorylation	 (Glibert	 et	 al.,	 2015;	 Lim	 et	 al.,	 2017).	 Secondly,	 chemical	
modification	 of	 ubiquitin	 with	 an	 isotopic	 carboxyethyl	 group	 following	 the	 initial	
trapping	experiment	would	enable	the	relative	quantitation	between	the	biological	
and	chemical	modifications.	This	approach	has	been	performed	in	acetylation	studies	
and	 has	 the	 advantage	 of	 reducing	 sample	 complexity	 (Gil	 et	 al.,	 2017).	 These	
approaches	 offer	 two	 complementary	 approaches	 to	 defining	 carbamate	
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stoichiometry	under	various	conditions.	It	is	expected	that	carbamylation	of	K33	and	
K48	relative	to	the	unmodified	peptide	would	change	in	a	dose-dependent	manner.	
However,	a	potential	difficulty	with	 the	use	of	 isobaric	 tags	 is	 that	 the	unmodified	
peptide	 will	 be	 cleaved	 at	 K33	 or	 K48.	 By	 taking	 the	 same	 approach	 as	 Gil	 et	 al.	
ubiquitin	 will	 be	 exclusively	 cleaved	 at	 arginine	 residues,	 thus	 streamlining	 the	
quantitation	process.	
	
4.3.2. In	vivo	applications	
At	present	 the	 trapping	 reagent	can	only	be	used	 in	vitro	or	ex	vivo.	 This	makes	 it	
difficult	to	observe	carbamylation	in	cellular	contexts	and	therefore	development	of	
a	cell	membrane-permeable	reagent	is	desired.	Such	a	reagent	would	also	ideally	be	
optimised	to	enrich	carbamylated	proteins.	Together,	this	would	provide	a	workflow	
for	enhanced	 identification	of	proteins	 susceptible	 to	carbamylation,	 thus	enabling	
identification	of	 the	 ‘carbamylome’.	Until	 such	a	probe	 is	developed,	a	proteomics	
investigation	to	identify	more	proteins	susceptible	to	carbamylation	could	be	achieved	
with	 SILAC.	 This	 is	 a	 technique	 that	 enables	 quantitative	 proteomics	 by	 labelling	
proteins	 in	vivo	with	 isotopic	 lysine	and	arginine	residues.	This	permits	up	to	three	
experimental	 conditions	 to	 be	 tested	 and	 for	 the	 proteins	 to	 be	 trapped	 ex	 vivo.	
Additionally,	 such	 an	 experimental	 setup	 could	 be	 used	 to	 observe	 the	 differing	
proteomes	of	 cells	 exposed	 to	hypercapnic	or	normocapnic	 conditions.	A	previous	
study	 compared	 two	 populations	 of	 eastern	 oysters	 that	 had	 been	 exposed	 to	
normocapnic	 or	 hypercapnic	 conditions.	 The	 authors	 of	 this	 study	 found	 that	 a	
relatively	 high	 proportion	 	 (12%	 of	 456)	 of	 identified	 proteins	 were	 differentially	
expressed	 in	 hypercapnia	 (Tomanek	 et	 al.,	 2011).	 This	 study	 leaves	 room	 for	
improvement	with	regards	investigating	proteome	depth	and	a	proteomic	analysis	of	
mammalian	cells	exposed	to	varying	 levels	of	CO2	could	provide	useful	 information	
regarding	some	of	the	previously	described	pathologies	associated	with	hypercapnia.	
To	 this	 end,	 a	 similar	 strategy	 has	 been	 performed	 at	 the	 genome	 level,	 which	
identified	an	effector	of	CO2	signalling	pathways	(Helenius	et	al.,	2016a).	
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A	possible	in	vivo	experiment	aimed	at	defining	the	dynamic	arrangement	of	ubiquitin	
under	elevated	CO2	is	to	expose	cells	to	hypercapnic	conditions	and	measure	changes	
to	ubiquitin	pools	using	a	protein	standard	absolute	quantification	assay	(Kaiser	et	al.,	
2011).	This	would	reveal	key	information	regarding	the	effect	of	carbamate	formation	
on	 ubiquitin	 crosslinking	 and	 the	 degree	 of	 substrate	 protein	 ubiquitination.	 Such	
insights	would	be	better	placed	 to	provide	 information	 regarding	 the	physiological	
relevance	 of	 carbamylation.	 Additionally,	 a	 novel	 fluorescence	 imaging	 technique,	
called	PolyUb-FC,	has	been	developed	to	inform	investigators	of	polyubiquitin	chain	
dynamics	 and	potential	 interactors	 (Nibe	et	 al.,	 2018).	 Since	 antibodies	 to	 atypical	
ubiquitin	 chains	 do	 not	 exist,	 it	 is	 not	 possible	 to	 derive	 this	 information	 from	 IP	
experiments	for	K33-linked	chains.	
	
4.3.3. In	vitro	applications	for	Ubiquitin	kinetics	
The	 formation	 of	 carbamates	 at	 K33	 and	 K48	 reverse	 the	 charge	 status	 of	 these	
residues.	 Research	 investigating	 other	modifications	 at	 lysine	 residues	 of	 ubiquitin	
indicate	that	a	change	in	charge	status	inhibits	isopeptide	bond	formation	(Ohtake	et	
al.,	2015).	Because	carbamylation	is	labile	it	is	unlikely	this	modification	fully	inhibits	
isopeptide	bond	formation.	It	was	therefore	hypothesised	that	carbamylation	at	these	
sites	reduces	rate	of	isopeptide	bond	formation.	A	ubiquitin	cross	linking	assay	was	
performed	 using	 E2-25K,	 which	 exclusively	 cross	 links	 at	 K48	 (David	 et	 al.,	 2010).	
Under	 hypercapnic	 conditions	 ubiquitin	 discharge	 from	 E2	 is	 inhibited.	 However,	
dimer	formation	occurs,	suggesting	carbamate	formation	does	not	inhibit	isopeptide	
bond	formation.	Therefore,	 it	can	be	concluded	that	carbamate	 formation	reduces	
the	rate	of	polyubiquitin	chain	formation.	This	 is	 in	agreement	with	other	research	
that	demonstrate	a	change	in	charge	status	reduces	the	rate	of	ubiquitination	but	not	
ubiquitin	binding	affinity	(Rodrigo-Brenni	et	al.,	2010).	The	experimental	setup	here	
was	limited	to	investigate	K48	crosslinking	at	high	CO2	concentrations.		
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Due	to	time	constraints	it	was	not	possible	to	complete	the	investigation	of	carbamate	
formation	on	ubiquitin	kinetics.	The	future	direction	of	this	project	would	have	been	
to	consider	the	following:	
• K33	 was	 also	 identified	 as	 a	 site	 of	 carbamylation.	 It	 will	 be	 important	 to	
confirm	 the	 effect	 of	 carbamylation	 on	 K33-linked	 polyubiquitin	 chain	
formation.	
• In	a	cellular	context	there	are	multiple	E2	and	E3	ligases	that	perform	ubiquitin	
crosslinking	at	the	8	sites	of	cross	linking.	It	would	be	informative	to	investigate	
whether	carbamylation	at	K33	and	K48	result	in	increased	crosslinking	of	other	
residues.	
• Within	a	cell	a	range	of	CO2	concentrations	will	be	experienced.	It	is	anticipated	
that	the	rate	of	ubiquitination	is	dose	dependant	and	that	this	would	correlate	
with	 the	 stoichiometry	 of	 carbamylation	 at	 various	 CO2	 concentrations.	 To	
investigate	this	the	cross-linking	assay	should	be	performed	over	a	range	of	
CO2	 concentrations.	 This	 investigation	 would	 complement	 a	 future	 mass	
spectrometry	based	assay	to	investigate	carbamate	stoichiometry		
	
4.4. Conclusion	
CO2	 is	 a	 fundamentally	 important	 to	 life.	 It	 is	 able	 to	 exert	 influence	 over	 cellular	
function	 through	 carbamylation	 of	 susceptible	 proteins	 involved	 in	 cell	 signalling	
pathways.	 Whilst	 many	 effects	 of	 elevated	 CO2	 in	 health	 and	 disease	 have	 been	
reported,	not	much	is	known	regarding	the	CO2	sensors.	Therefore,	the	aim	of	this	
project	was	initially	to	identify	a	CO2	sensor	and	define	the	mechanism	through	which	
CO2-dependent	 regulation	 occurs.	 Due	 to	 time	 constraints,	 however,	 this	 was	 not	
performed	to	completion.	A	MS	based	approach	defined	K33	and	K48	of	ubiquitin	as	
sites	 of	 carbamylation	 and	 a	 functional	 assay	 demonstrated	 the	 reduced	 rate	 of	
ubiquitination	 upon	 K48	 carbamylation.	 This	 is	 consistent	 with	 other	 reports	 that	
observe	reduced	rates	of	ubiquitination	upon	a	change	of	charge	status	to	targeted	
lysine	 residues.	 The	 implications	 of	 this	work	 are	 not	 clear	 but	 a	 potential	 role	 in	
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reducing	 metabolic	 burden	 has	 been	 outlined.	 Future	 work	 is	 required	 to	 better	
understand	ubiquitin	 carbamylation.	 First,	 the	 factors	 governing	 carbamylation	are	
poorly	understood.	 It	 is	 not	 yet	 known	what	 the	occupancy	of	 carbamylation	 is	 at	
various	 CO2	 concentrations	 or	 how	 the	 carbamate	 is	 stabilised.	 Second,	 the	 direct	
impact	 of	 elevated	 CO2	 on	 ubiquitin	 dynamics	 and	 its	 association	 with	 substrate	
proteins	 requires	 investigation.	 Finally,	 more	 information	 regarding	 ubiquitination	
kinetics	of	K33	and	K48	is	desired.	Overall	this	project	has	provided	evidence	of	a	novel	
CO2	 sensor	 and	 provides	 a	 platform	 for	 future	work	 to	 elucidate	 the	 physiological	
consequences	of	this	interaction.	 	
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